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We develop a series of mathematical models incorporating proposed mechanisms underly-
ing the development of two essential features of long-term type 2 diabetes progression: insulin
resistance and β-cell dysfunction. Reduced insulin-stimulated plasma glucose uptake (insulin
resistance) and inadequate insulin production by β cells (β-cell dysfunction) lead to a number
of metabolic irregularities. We study the interaction of oxidative stress and mitochondrial dys-
function in the development of skeletal muscle insulin resistance, focusing on mitochondrial
superoxide production and the functional and physical heterogeneities among mitochondria.
We explore primary determinants in β-cell failure, from the perspective of endoplasmic reticu-
lum stress and the unfolded protein response. We conclude with a basis for age-related insulin
resistance, an explanation of the fundamental role of nutrient excess in the decline of metabolic
health, and an identification of the interplay of cellular and molecular mechanisms important
in metabolic dysregulation.
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Type 2 diabetes mellitus is an epidemic that affects more than 25 million individuals in
the United States and an additional 330 million worldwide [19]. As the seventh leading cause
of death in the United States, it significantly increases the risk of cardiovascular disease and
stroke and costs hundreds of billions of dollars each year in healthcare, work loss, disability
services [3]. Yet, there is no cure.
There are two major players in diabetes manifestation: glucose and insulin. The disease
itself is defined by excessive plasma glucose concentrations, i.e., hyperglycemia, brought on by
insulin insufficiency. Glucose is utilized by most cells to create energy and can be produced
by the liver or external sources, such as food. Insulin is its major inhibitor and is secreted by
pancreatic β cells in response to elevated glucose to facilitate cellular glucose uptake from the
blood [25, 36]. Type 2 diabetes is one of two major classes of diabetes, the other being type
1 diabetes. The latter results from an immune-mediated destruction of pancreatic β cells and
is usually diagnosed in childhood. Individuals with type 1 diabetes produce very little to no
insulin and thus require exogenous insulin to regulate glucose concentrations. Furthermore,
precipitating events that initiate complete β-cell loss lead to a rapid progression of overt dia-
betes [57]. Type 2 diabetes, on the other hand, is characterized by a relative insulin deficiency,
wherein the insulin that is secreted from β cells is insufficient to meet metabolic demands. This
disease is often associated with obesity, is diagnosed later in life, and has a slow progression
[100].
Genetic and environmental susceptibility factors determine the presence of type 2 diabetes
in the general population. Yet, the onset of disease results from any combination of a multi-
tude of genes and environmental components, which can ultimately affect several aspects of
metabolic regulation, so that the development of such a complex disease cannot be explained
by a characteristic set of susceptibility factors [53, 69]. Nevertheless, there are two conditions
that are central to disease development, and several mechanisms have been proposed to ex-
plain their individual progression. First, the majority of type 2 diabetics exhibit reduced re-
2sponsiveness to insulin, called insulin resistance. Second, β cells of susceptible individuals do
not secrete enough insulin to meet metabolic demands, defining a state of β-cell decompensa-
tion, dysfunction, or failure [66, 78]. Together, insulin resistance and β-cell dysfunction define
a timeline to diabetes. Eventual type 2 diabetics exit a state of normal glucose metabolism, in
which insulin sufficiently caters to metabolic requirements, and enter one of insulin resistance,
which can reduce glucose uptake from the blood or increase endogenous glucose production.
A compensatory response by β cells increases plasma insulin levels, causing hyperinsulinemia.
This condition can last for several years, until β-cell decompensation occurs, initiating the
severe hyperglycemia that defines the overt diabetic state [100].
Although insulin resistance and β-cell decompensation compose the well accepted basis of
type 2 diabetes, the molecular mechanisms underlying their development are incompletely un-
derstood [53,69]. In this work, we present long-term mathematical models describing proposed
mechanisms to assess their roles in metabolic regulation and disease progression (Figure 1.1)
and to fill the gap in existing long-term models of type 2 diabetes [24,96], which do not provide
a mechanistic basis for these fundamental pathological conditions.
In this work, we define type 2 diabetes as a disease that coordinates metabolic dysfunction
on multiple biological levels, including plasma, cellular, intracellular, and molecular. Abnor-
malities on the plasma scale are caused by tissue and cellular defects, which are themselves
acquired by intracellular and molecular impairments. At the tissue and cellular levels, we
restrict ourselves to dynamics associated with skeletal muscle and β cells for the following
reasons: Skeletal muscle accounts for roughly 75% of all insulin-mediated glucose uptake upon
meal ingestion, and in type 2 diabetics, the rate at which glucose is utilized is decreased by 50%
[25,87]; type 2 diabetes development requires β-cell dysfunction on top of insulin resistance, as
insulin resistance alone cannot produce diabetes [7, 47, 66]. We therefore explore mechanisms
underlying the progression of both skeletal muscle insulin resistance and functional compen-
sation and decompensation by β cells.
Insulin resistance is characterized by impaired insulin signaling, in which elements of the
associated pathway reduce insulin’s ability to adequately facilitate cellular glucose uptake [48,
101]. Of the proposed mechanisms for skeletal muscle dysfunction, we center our work on
the effects of dietary excess in the development of oxidative stress and the related dysfunc-
tion of energy-producing mitochondria. Oxidative stress is an accumulation of toxic reactive
oxygen species, which are standard by-products of glucose metabolism and energy production























































































































































































































































































































































































































































































































































































4mitochondrial dysfunction can arise from excessive generation of reactive oxygen species and
can provide positive feedback for oxidative stress [44]. We highlight these as important mech-
anisms in the progression of skeletal muscle insulin resistance because of their connection to
the insulin signaling pathway and their potential for systemic dysfunction.
β-cell function is defined by insulin production and β-cell expansion, both of which in-
crease in response to glucose [100]. The proposed mechanism for β-cell dysfunction lies in
the unfolded protein response mounted by the endoplasmic reticulum in conditions of stress.
This response, a protective mechanism to prevent β cells from being overworked, can be ac-
tivated by a prolonged, increased demand for insulin [66]. However, when the response itself
is activated for too long, which reflects an inability to restore cellular homeostasis, apoptotic
pathways can be triggered [7]. The mechanism of β-cell failure suggested by the unfolded pro-
tein response allows for a biological description of insulin production, while providing essential
feedback in the presence of elevated insulin requirement. This mechanism also addresses the
notion of β-cell loss, which has been associated with type 2 diabetes, albeit with widely varying
results [18, 40, 77].
It is evident that type 2 diabetes is a symphony of dysfunction, as its pathogenesis relies
heavily on the interplay of destructive mechanisms that cause both insulin resistance and β-
cell failure. We use subsequent chapters to present mathematical models of these long-term
processes and their effects on glucose regulation. Chapter numbers and their corresponding
mechanisms appear in Figure 1.1. In Chapter 2, we develop a deterministic model of the
production of mitochondrial superoxide, a type of reactive oxygen species, and the effects of
exogenous glucose on the presence of oxidative stress. In Chapter 3, we use deterministic and
stochastic methods to model heterogeneities among mitochondria within skeletal muscle cells,
along with feedback between oxidative stress and mitochondrial damage. In Chapter 4, we uti-
lize a continuous model of the insulin signaling pathway, modulated by reactive oxygen species
and mitochondrial damage, to create a mechanistic model of the progression of skeletal muscle
insulin resistance. In Chapter 5, we deterministically model β-cell function at the molecular
and population levels, as affected by the unfolded protein response, and we explore the effects
of insulin resistance and β-cell dysfunction on glucose regulation. Finally, we use Chapter 6 to
summarize and outline future extensions of the work presented herein.
CHAPTER 2
MITOCHONDRIAL PRODUCTION OF REACTIVE
OXYGEN SPECIES IN GLUCOSE
DYSREGULATION
Glucose is a major source of cellular energy and is utilized in many tissues including neural,
skeletal muscle, hepatic and adipose tissues. Exogenous and endogenous sources, such as
diet and liver production, respectively, add to plasma levels [25, 95]. Excess glucose can lead
to severe health complications, including type 2 diabetes mellitus. For this reason, effective
regulation by pancreatic hormones is required.
The pancreas comprises two major cell types: exocrine and endocrine. Exocrine cells, which
include acinar and duct cells, are essential in the digestive process. Scattered among acini are
endocrine cells, which are hormone-secreting cells located in the numerous pancreatic Islets
of Langerhans. Together, these cells account for 1−2% of the entire human pancreas [75, 86]
and are composed of α, β, δ, ε, and PP cells [38]. The islets predominately contain α and
β cells, the latter accounting for 50− 80% of all islet cells [68, 75, 86]. Both cell types have
significant roles in regulating glucose homeostasis: Glucagon from α cells, secreted in response
to low plasma glucose concentrations, leads to increased hepatic glucose output and reduced
glycolysis; β-cell-derived insulin reduces blood glucose levels by stimulating glucose transport
into target tissues and suppresses hepatic glucose production [23, 75].
A reduced physiological response to normal amounts of insulin is termed insulin resis-
tance, which is characterized by an impairment in the insulin signaling pathway of hormone-
responsive cells and is a major factor in type 2 diabetes pathogenesis. Although insulin resis-
tance occurs on the whole-body level, skeletal muscle is a primary culprit in its development,
as the majority of insulin-stimulated glucose uptake occurs in this tissue type [10, 25]. In the
absence of other dysfunction, it is unclear how skeletal muscle fibers become and remain in-
sulin resistant and how this state propagates throughout the majority of skeletal muscle tissues
[1,43], but the mitochondrion has been implicated as an integral piece of the puzzle [13,43,49].
Glycolytic end-products are utilized to facilitate energy production within this organelle, which
6connects energy demand to nutrient availability. During this process of cellular respiration,
toxic reactive oxygen species (ROS) are generated as a typical by-product. These are readily
removed by protective antioxidant mechanisms present in mitochondria and cytosol alike, but
cellular or mitochondrial dysfunction, along with nutrient excess, can alter the removal efficacy
and rate of production, leading to an accumulation of ROS, termed oxidative stress [31].
In the presence of such stress, mitochondria can undergo a variety of changes, particu-
larly in their deoxyribonucleic acid (DNA), which is notoriously susceptible to oxidative stress-
mediated mutagenesis and damage [4, 52]. Because skeletal muscle tissue is post-mitotic, nu-
clear DNA modifications are considerably less common, and the effects of cytosolic ROS are
more often manifest in the activation of cellular stress signals and their downstream targets
[8, 10]. The insulin signaling cascade is one such target, highlighting the basis of the oxidative
stress-centered hypothesis in the development of insulin resistance [94].
Generated primarily by muscle mitochondria, superoxide is a highly toxic ROS. Intracel-
lular and mitochondrial protective mechanisms, such as superoxide dismutase, prevent most
superoxide from causing damage. The manganese form of superoxide dismutase (MnSOD)
resides in the mitochondrial matrix, and its reaction with superoxide results in the formation
of hydrogen peroxide, a less toxic ROS [35] that can impede insulin signaling [104]. Thus, in
order to determine how insulin resistance develops, it is essential to understand mitochondrial
superoxide production and its effects, which is the focus of this chapter (Figure 2.1, blue text).
This component of insulin resistance progression can then give way to additional mechanisms
that are associated more directly with dysfunctional glucose uptake (Figure 2.1, black text).
Mitochondrial superoxide production is primarily the result of intracellular glucose metabo-
lism (Figure 2.2). Upon entering the skeletal muscle cell, glucose is broken down into pyruvate,
which then enters the mitochondrial matrix and produces pairs of electrons that pass through
the electron transport chain (ETC). Each electron pair travels through ETC Complexes I and
III, initiating a series of redox reactions that allow complex proteins to switch between oxi-
dized and reduced states [88]. These reactions release energy that is used to pump protons
from the matrix into the intermembrane space, generating a potential gradient. At complex
IV, the electrons are passed to free oxygen and matrix protons to create water molecules. The
electrochemical potential energy created by the proton gradient in the intermembrane space
is used to power adenosine triphosphate (ATP) production, after which protons can flow back
into the matrix. Electrons can also be dropped from the ETC, which allows them to react with
the abundant oxygen molecules to form superoxide.
7Figure 2.1. Illustration (blue text and symbols) of the primary focus of Chapter 2. Glucose
or nutrient excess generates increased concentrations of mitochondrial superoxide, which are
elevated further by intramitochondrial feedback. This leads to a state of oxidative stress within
mitochondria and a role for superoxide in the progression of insulin resistance. O·−2 : superox-
ide; H2O2: hydrogen peroxide.
Figure 2.2. Oxidative phosphorylation and superoxide production. Glucose metabolism gives
rise to pyruvate, which is transported into the mitochondrion. A series of redox reactions result
in the generation of electron pairs that are to flow through the electron transport chain (ETC).
Complexes I and III contain a myriad of proteins that are alternately reduced and oxidized.
These reactions create energy used to pump protons from the mitochondrial matrix into the
intermembrane space, thus generating a potential gradient. At the end of the chain, electrons
are used to form water, and the electrochemical energy is used to power ATP production,
allowing protons to return to the matrix. Electrons in Complexes I and III can leak from the
ETC into the mitochondrial matrix, allowing for their reduction of oxygen to form superoxide.
The anion is detoxified by antioxidant enzyme MnSOD, yielding hydrogen peroxide. ADP:
adenosine diphosphate; ATP: adenosine triphosphate; e−: electron; H+: proton; H2O: water
molecule; H2O2: hydrogen peroxide; MnSOD: manganese superoxide dismutase; O2: oxygen
molecule; O·−2 : superoxide.
8Energy use provides positive feedback on its production, but in a state of lower ATP utiliza-
tion, the rate of glycolysis slows, resulting in decreased energy production. A combination of
reduced energy use and heightened glucose uptake, which can represent a sedentary lifestyle
and overeating, results in an excess of ATP, a depletion of adenosine diphosphate (ADP), and
an elevated proton gradient. If the potential energy created by protons cannot be released,
electron flow is retarded, but the constant influx of nutrient-derived electrons causes them to
aggregate in complexes I and III. Electron leakage into the mitochondrial matrix then becomes
more likely, resulting in increased rates of superoxide production [99].
In this chapter, we develop a mathematical model of mitochondrial superoxide production
to determine the effects of nutrient overload on the oxidative state of skeletal muscle cells.
2.1 Model of mitochondrial superoxide production
Figure 2.3 is a schematic of the full model, which contains two major components: the
glucose-insulin regulatory system and the intramitochondrial system.
2.1.1 Glucose-insulin subsystem
The glucose-insulin regulatory system is the point of contact for many metabolic abnormal-
ities (Equations (2.1)). The state variables for this subsystem are plasma glucose, G(t ); plasma















=v1 ·SG I −kg i Gi . (2.1c)
• Plasma glucose. Sources of glucose include both endogenous and exogenous factors.
Most of the internally created glucose is derived from the liver, while diet provides ex-
ternal glucose. Removal of glucose from the blood can occur via insulin-dependent and
-independent means. While the brain takes in glucose at a constant rate and indepen-
dently of any other signals, skeletal muscle cells require insulin to facilitate glucose inter-
nalization [25]. The Bergman Minimal Model for the assessment of insulin sensitivity,
which models the changes in plasma glucose and an insulin action variable, is often
used to describe glucose dynamics [11]. The insulin action compartment serves as a
transitional reservoir for plasma insulin input and is assumed to facilitate glucose uptake
directly, thus representing the delay between insulin appearance in the blood and its
9Figure 2.3. Details of the mitochondrial superoxide production model. Glucose uptake leads to
ETC activation and ATP production. A fraction qr of cellular respiration results in superoxide
formation, with the remainder dedicated to energy production. Superoxide reduces mitochon-
drial efficiency in generating ATP, thereby decreasing the fraction of proper respiratory activity
and increasing its own production. Superoxide also enhances MnSOD production, which works
to remove the anion from the mitochondrion. ATP: adenosine triphosphate; ETC: electron
transport chain; MnSOD: manganese superoxide dismutase; O·−2 : superoxide.
regulatory action on glucose. Because glucose and insulin responses occur on the order
of minutes, subsequent adaptations of the Minimal Model that account for long-term
dynamics [24, 96] make a quasi-steady state approximation of insulin action, resulting
in a single equation to describe the change in plasma glucose. This is the form used in
Equation (2.1a).
The source term hg describes endogenous glucose production from the liver, while
insulin-independent plasma glucose uptake occurs at a constant rate kg . To reflect the
dependence of peripheral tissues on insulin, the rate of uptake is assumed to be propor-
tional to the concentrations of glucose and insulin with constant rate parameter S, often
referred to as the insulin sensitivity parameter [12, 24, 96].
We modify the form of previous models with the time-dependent rate parameter σ(t ),
which accounts for dietary intake and consequent glucose absorption into the blood. σ
varies according to the average daily change from baseline (G0) in the glucose area under
the curve, which we denote by ∆AUC (Figure 2.4). Let T be the appropriate number of
time units in a given day. Then
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Figure 2.4. Sample 24-hour glucose profile and illustration of ∆AUC. The fasting glucose area
under the curve is given by G0T . Each peak corresponds to the ingestion of a meal (↑) and
subsequent appearance in the blood. The net area beneath these three curves is the cumulative
change above fasting and the average change is this quantity divided by T . ∆AUC is defined to










G(t ) dt −G0.
We assume that a glucose concentration of G0 corresponds to hepatic input hg , so that σ




In our model exploration, we simulate daily meals by defining σ(t ) as a square wave.
The wave amplitude is then scaled according to the meal duration to ensure that the
integrated wave over 24 hours equals the right-hand side of (2.2).
• Plasma insulin. The rate of insulin secretion is a sigmoidal function of glucose [36]. From
the work of De Gaetano et al. [24], hormone production and release is modeled by a Hill
function with coefficient 4 and maximal production rate hi B , where B represents the
number of β cells present (Equation (2.1b)). Insulin is cleared from the blood with rate
constant ki .
Following an increase in blood glucose, β cells secrete insulin to allow for the return
of glucose to its basal concentration, which is the typical metabolic response to dietary
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intake. Although glucose always stimulates β-cell release of insulin into the blood, this
secretion saturates for ever-increasing concentrations of glucose. β cells may adapt to
changes in metabolic demand by either increasing their mass or function [86], and to
eliminate the effects of compensatory β-cell behavior in the present framework, we as-
sume B is constant.
• Intracellular glucose. The full amount of glucose removed from plasma is distributed
evenly among skeletal muscle cells with conversion factor v1 (Equation (2.1c)). Further,
glycolysis, the process by which intracellular glucose is broken down for use in cellular
respiration and subsequent ATP production, occurs at a constant rate kg i . We apply
this assumption presently to reduce the biological complexity of ATP production and
utilization dynamics.
2.1.2 Mitochondrial subsystem
Glycolysis results in the creation of pyruvate, which is subsequently transported into the
cell’s mitochondria, setting the electron transport chain in motion. Because mitochondria are
responsible for most superoxide produced in skeletal muscle fibers, we construct a model of
the processes operating within an individual organelle (Figure 2.3). The model comprises two
main pieces, one describing the ETC (Equations (2.3)), the other describing the causes and
effects of superoxide (Equations (2.4)). The six state variables represented are oxidized and
reduced ETC complex, Cox (t ) and C (t ); superoxide, Rs(t ); antioxidant enzyme MnSOD, As(t );

































• Electron transport dynamics. We condense the ETC complexes into a single represen-
tative entity; the proteins housed in this complex can assume either an oxidized or a
reduced state (Equations (2.3a) and (2.3b)). Glucose processing results in the immediate
donation of electrons to the ETC, where Ne is the number of electrons created per glucose
concentration and v2 accounts for pyruvate entry into a single mitochondrion. The trans-
fer of electrons leads to a reduction reaction, transferring proteins from the oxidized state
(Cox ) to the reduced state (C ). Because the release of electrons immediately precedes
ATP production, we assume these events occur in tandem; therefore, the electron-free
complex returns to an oxidized state with rate kc (1− qr ). A fraction qr of respiration
leads to the formation of superoxide, which also decreases the contribution of reduced
complex toward ATP production.
Based on studies of isolated mitochondria, between 0.12% and 4% of all cellular res-
piration is thought to result in superoxide formation [8, 31, 49, 98]. However, the in vivo
percentage is most likely much smaller due to experimental conditions [67]. Specifically,
the supraphysiological concentrations of ETC substrates and oxygen used in isolation
favor the reduction of ETC complexes; with higher oxygen concentrations, the likelihood
of electron transfer from reduced substrates to oxygen increases further [32]. Therefore,
we assume qr is small.
Mitochondrial dysfunction increases with age, and the source of such dysfunction is
believed to be an accumulation of mutations in mitochondrial DNA (mtDNA) [9, 14, 44].
The proximity of the site of superoxide production to that of mtDNA enhances mitochon-
drial susceptibility to mutagenesis, which results in a progressive increase in mutation
number. When 35% of mtDNA encodes for genes involved in electron transport, it stands
to reason that an increased mutation number will affect proper electron transport [92].
We assume oxidation is slowed by mitochondrial inefficiency, L, which increases with
age. Such dysfunction is presumed to affect the proper transport of electrons through the
entire complex. Therefore, the rate at which ATP production proceeds is limited by the
efficiency factor (1−L). It is also assumed that L progresses uniformly in all mitochondria.
Because the right-hand sides of Equations (2.3a) and (2.3b) sum to zero, Ctot =Cox+C
is constant, and Cox =Ctot −C . Substituting into Equation (2.3b) gives
dC
dt
= v2Ne ·kg i Gi (Ctot −C )−kc [(1−qr )(1−L)+qr ]C (2.4e)
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to describe the dynamics of the electron transport chain complex in terms of its reduced
form.
• Superoxide. Equation (2.4a) describes the change in the concentration of mitochondrial
superoxide over time. The sole source of superoxide is electron leakage from the reduced
ETC complex, and the rate of antioxidant-mediated dismutation is first-order with re-
spect to superoxide and MnSOD.
• Manganese superoxide dismutase. Nuclear translation of MnSOD requires an upregula-
tion signal with the ability to communicate between superoxide and transcription ma-
chinery. Such a signal may come from NF-κB, FoxO, and CREB proteins, which respond
to elevated superoxide levels [65, 73]. Although superoxide is eliminated by antioxidants,
its highly toxic nature subjects mitochondria and their proteins, antioxidant enzymes
included, to oxidative damage.
We therefore model MnSOD along with its translation signal (Equations (2.4b) and
(2.4c)). MnSOD is produced at maximal rate aa , scaled by the strength of its translation
signal, which ranges from zero and one. To reflect the potential damage to MnSOD
caused by superoxide, we assume that a small fraction qa of the MnSOD-superoxide
reactions lead to antioxidant degradation; the enzyme MnSOD is otherwise undamaged.
Inactive translation signaling, (1−E), may be activated with an increase in superoxide at
rate ae . In the absence of superoxide stimulation, this signal decays by reverting to its
inactive form.
• Mitochondrial inefficiency. Superoxide is often generated near the ETC, which is in close
proximity to mtDNA molecules in the inner mitochondrial membrane. Mutagenic le-
sions are formed when superoxide oxidizes guanine bases in the mtDNA, which leads to
higher mutation frequencies. The mutations themselves may slowly accumulate in mi-
tochondria when repair mechanisms fail, which is why mitochondria of aging organisms
are characterized by a number of mtDNA mutations that have developed over several
decades [9, 76].
We let L denote the fractional inefficiency of mitochondria due to the build up of
mutated mtDNA (Equation (2.4d)) and assume that concentrations of Rs greater than
the basal level, Rs0, lead to the progressive deterioration of mitochondrial ETC function.
Because mitochondrial dysfunction changes very slowly, the rate parameter ξ is small
compared to the others in this subsystem.
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2.2 The effect of glucose input
To assess the role of exogenous glucose in superoxide production, we numerically solve
Equations (2.1) and (2.4) for a period of 120 years with hourly increments, according to the pa-
rameters in Table 2.1. For these solutions, we vary the nutrient intake parameter σ periodically
according to the formula (2.2), with ∆AUC ranging between 0 and 4.0 [17]. Henceforth, model
results will be discussed in terms of ∆AUC. A description of all parameters appears in Table 2.1.
We present trajectories for intracellular glucose (Gi ), the ETC complex (C ), superoxide (Rs),
MnSOD translation activity (E), MnSOD (As), and mitochondrial inefficiency (L) over a 120-
year period (Figure 2.5). The system is assumed to be in equilibrium at t = 0 for ∆AUC = 0,
and the corresponding initial conditions are made identical for all ∆AUC. With the exception of
mitochondrial inefficiency, each variable experiences rapid oscillations due to the daily glucose
input, the wide bands reflecting the short-term response of the system. Intracellular glucose, as
expected, exhibits higher amplitudes with increased ∆AUC, promoting the reduction of the ETC
complex. More dramatic oscillations and elevated levels of reduced complex are associated
Table 2.1. Parameter descriptions for Equations (2.1) and (2.4). A summary of all values used
appears in Table A.1.
Parameter Description Units
aa MnSOD production min
−1
ae MnSOD signal activation min
−1
B β-cell mass 106 cells
Gh half-maximal glucose stimulation mM
hg hepatic glucose production mM min
−1
hi insulin production (10
6 cells)−1 min−1
kc cellular respiration min
−1
ke MnSOD signal deactivation min
−1
kg insulin-independent glucose uptake min
−1
kg i glycolysis min
−1
ki insulin clearance min
−1
kr s superoxide dismutation µM
−1 min−1
Ne produced electrons mM
−1
qa MnSOD damage probability #
qr fractional superoxide production #
S insulin sensitivity parameter pM−1 min−1
σ food intake parameter mM min−1
v1 glucose distribution factor #
v2 ETC conversion factor #
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Figure 2.5. Long-term trajectories for the mitochondrial variables of the superoxide production
model for various ∆AUC. Wide bands reflect rapid daily oscillations.
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with larger ∆AUC, leading to increased superoxide production. The strength of the MnSOD
translation response is heightened in the presence of superoxide, leading to fluctuating MnSOD
concentrations. However, the antioxidant itself oscillates at lower levels as ∆AUC increases.
Finally, mitochondrial inefficiency dictates long-term dynamics, as it rises slowly over time.
Progressive mitochondrial dysfunction leads to a slow increase in the reduction of the ETC
complex, which in turn increases superoxide production. With a further decline in antioxidant
capacity, superoxide levels continue to rise, well beyond the low steady-state level of 10−5 µM.
Higher dietary intake, as measured by ∆AUC, hastens the process of destruction. There exists
an unrealistically large equilibrium concentration of superoxide as time progresses indefinitely
(not shown). Below a critical MnSOD threshold, which depends on existing mitochondrial
dysfunction, the superoxide concentration will experience a more drastic elevation. Eventually,
the ever-declining antioxidant capacity results in extreme superoxide levels, for any positive
∆AUC.
The full model of mitochondrial superoxide production highlights two important feedback
loops from the perspective of superoxide concentration. On the one hand, there exists a posi-
tive feedback of superoxide on its own production, by way of mitochondrial inefficiency. In the
short term, superoxide is created as a simple by-product of cellular respiration. However, the
slower decline in mitochondrial function eventually decreases the amount of reduced complex
used for ATP production. The result is a larger pool of reduced complex available for electron
leakage and subsequent superoxide generation. The persistence of such interactions generates
further organelle dysfunction and still higher superoxide concentrations.
Because superoxide stimulates the production of MnSOD, it facilitates a process that pre-
dominately leads to its own decline. In the short term, the efficacy with which MnSOD dismu-
tates superoxide successively controls anion concentrations in a negative feedback loop. Fur-
ther increases in superoxide produce more MnSOD within the limits of the translation signal.
The longer term process of slight antioxidant damage, combined with the positive feedback,
shifts the balance in favor of superoxide.
2.2.1 Time-scale analysis
To determine the relative effect of mitochondrial inefficiency and nutrient excess on the
production of superoxide, we carry out a time-scale analysis on the present model. The slow
dynamics of L(t ) allow for the rescaling of time based on the order of ξ. Let τ = εt for ε
satisfying ξ = εξ¯. We may then rewrite the full system, with each variable redefined in terms
17







































Equations (2.5a) – (2.5g) define the fast subsystem of the model, while the slow subsystem
is characterized by a single equation, (2.5h). The steady states of Equation (2.5h) are given by
Rs = Rs0 and L = 1. Because the system is assumed to originate at equilibrium, we treat L as
a parameter to determine its effect on the dynamics of the fast variables prior to reaching the
terminal state of L = 1. In particular, we assume that ε is sufficiently small such that for each
change in L, the fast subsystem has arrived at an equilibrium. Thus, as ε→ 0, we can calculate
the quasi-steady-state expressions for the fast variables and make a series of substitutions to
obtain a single formula for superoxide, Rs , as a function of both mitochondrial inefficiency
L and meal intake parameter σ. Assuming a negligible effect of insulin-independent uptake
(kg = 0),
Rs(σ,L)=
v1v2qa qr kc ke NeCtot (σ+hg )
ae
{
v1v2Ne (σ+hg )(aa −qa qr kcCtot )+aakc [(1−qr )(1−L)+qr ]
} . (2.6)
The right-hand side of Equation (2.6) is positive provided the denominator
Θ= ae
{
v1v2Ne (σ+hg )(aa −qa qr kcCtot )+aakc [(1−qr )(1−L)+qr ]
}
(2.7)
is positive. Under certain combinations of L and σ, this expression may also equal zero exactly,
thus defining the line Θ = 0 as the catastrophic barrier. Figure 2.6 depicts the areas in which
superoxide concentration exceeds physiological limits, as well as the impact of interactions


















Figure 2.6. Map of steady-state superoxide in the fast subsystem based on ∆AUC and mito-
chondrial inefficiency. MT: mitochondrial.
As ∆AUC, and hence σ, increases, superoxide follows suit, even in the absence of mitochon-
drial dysfunction. The progression of inefficiency amplifies the effect of higher glucose input,
to the extent that lower levels of mitochondrial inefficiency are sufficient to catapult superoxide
well beyond reasonable limits.
2.3 Discussion
The model of superoxide production and damage highlights several important factors re-
garding the role of mitochondria in oxidative stress, along with the feedback mechanism un-
derlying its development. Slow changes in mitochondrial inefficiency enhance the detrimental
production of toxic superoxide. Many short-term feedback processes maintain a functioning
metabolic system, such as the compensatory response in antioxidant production. However,
the benefits of this response are reduced by superoxide’s own destructive effects, particularly in
the presence of nutrient excess.
The current model gives a semimechanistic view of superoxide production and identifies
important features underlying it, but does so with a level of reduced complexity. A major
simplification in the model is the omission of ATP dynamics and its impact on cellular glucose
processing. The glycolytic pathway has several built-in feedback mechanisms that protect the
cell and its machinery. In a state of low energy use and high glucose intake, there is an increase
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in the cytosolic concentration of ATP. Glycolysis slows in the event of energy excess, resulting
in a reduction of pyruvate entry into the mitochondrion and therefore diminished electron
transport activity, which reduces superoxide production.
ATP availability depends on the ATP/ADP antiporter, which exchanges one molecule of
mitochondrial ATP for cytosolic ADP. The total cellular concentration of adenine nucleotides
remains fairly constant, which highlights the importance of energy utilization in electron trans-
port. Once mitochondrial ADP is converted to ATP, a molecule of cytosolic ADP is required
to transport newly formed ATP from the mitochondrion for cellular benefit. However, in the
event of low energy utilization, fewer cytosolic ATP molecules are converted back into ADP,
which reduces this molecule’s presence in the cytosol. A deficiency in cytosolic ADP results in
a buildup of mitochondrial ATP. Continued ATP production, within the limitations of the trans-
membrane potential, results in depletion of mitochondrial ADP [29]. If this occurs, electron
transport activity stalls because of the large number of protons that have been pumped into the
intermembrane space to power ATP production. A maximal electrochemical gradient potential
prohibits further pumping of protons, which is required for the flow of electrons. Electrons
already present in the ETC are then trapped, thus increasing the likelihood of leakage into the
mitochondrial matrix and the consequent reduction of existing oxygen molecules [99]. ATP can
both prevent and promote excessive mitochondrial superoxide production, and we eliminate
these opposing actions by restricting ourselves to the general effects of nutrient overload and
implicit ATP production.
In this chapter, we have described superoxide production and the positive feedback intro-
duced by ROS-mediated mitochondrial dysfunction within an individual mitochondrion. The
present model highlights defects of individual organelles from the perspective of ROS over-
production, but the progression of insulin resistance requires cellular dysfunction as well. We
can exploit the former to describe the underlying causes of the latter. Heterogeneities among
cellular components, such as mitochondria, and their relationship to superoxide can provide
insights that extend beyond the current framework.
CHAPTER 3
THE DYNAMICS OF MITOCHONDRIAL
DYSFUNCTION
Mitochondria are often referred to as the powerhouse of the cell. They are responsible for
creating sufficient energy for normal cellular function, and they are capable of adapting their
output to changing energy demands. In insulin resistance, they produce damaging superoxide
anions that, in turn, do them harm. Like many machines, these organelles are susceptible to
functional modifications that reduce their benefit to the cells in which they live. Mitochondrial
alterations are often manifest in mutations to their DNA, but may extend to more general
components, such as their size and ability to replicate [93, 107]. Through an integrated signal
of health, the characteristics of the individual powerhouses can impact cellular-level functions,
such as insulin signaling, thus highlighting a role for mitochondrial heterogeneity in the pro-
gression of insulin resistance (Figure 3.1).
Individual cells contain several hundred mitochondria, each of which in turn carry several
copies of its mtDNA. A single cell thus contains thousands of mtDNA copies [92]. Given that
mtDNA experiences rapid turnover, the composite effect of heterogeneous mtDNA and high
Figure 3.1. Illustration (blue text and symbols) of the primary focus of Chapter 3. Damage in
an individual mitochondrion is selectively favored, as the cellular population of organelles con-
tinues to be infiltrated with damage. These mitochondria provide feedback to both cellular and
mitochondrial function, supporting a role for mitochondrial heterogeneities and abnormalities
in the progression of insulin resistance. O·−2 : superoxide; H2O2: hydrogen peroxide.
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susceptibility to further mutations make repair mechanisms relatively inefficient [52]. The
existence of multiple mtDNA copies with varying alterations is called heteroplasmy. This state,
for any given mitochondrion, confers higher susceptibility to additional mutations upon the
entire mitochondrial population. Mitochondrial fission can reduce the threat of heteroplasmy
by diminishing the level of mtDNA mixing between different mitochondria, but this process is
imperfect. As a last resort, mitophagy (mitochondrial autophagy) facilitates organelle turnover
[27, 93, 99].
Oxidative stress increases the mutation rate of mtDNA, and hence, the likelihood of hetero-
plasmy. It also compromises the integrity of the mitochondrial permeability transition pore,
leading to an influx of water and consequent swelling [107]. An increase in the volume of
these damaged organelles decreases susceptibility to the protective scavenging mechanisms
that carry out mitophagy, thus reducing their turnover rates in comparison to their healthier
counterparts [64]. Further, damaged mitochondria are believed to have a replicative disadvan-
tage [51], which may result from diminished responses to fission-inducing signals [93]. These
ideas highlight two main differences between oxidatively damaged organelles and those ex-
periencing normal levels of mutation: Mitophagy regulates the presence of excessive mtDNA
heterogeneity within a single entity, but becomes less effective with oxidation-induced alter-
ations; less defective mitochondria are better able to reproduce. Additionally, the physical and
functional abnormalities accrued lead to increased ROS production [44], suggesting a role for
the propagation of a damaged phenotype within the whole-cell population of mitochondria.
In this chapter, we develop a mathematical model to describe selection in the mitochondrial
population and explore its role in intracellular metabolic processes.
3.1 Models of mitochondrial selection
Given the changes in growth and turnover acquired by damaged mitochondria, we develop
a mathematical model to describe damage selection in the cellular mitochondrial population.
Although several levels of damage can exist, we consider two primary classes of mitochondria:
undamaged and damaged (Figure 3.2). Let C0 and C1 denote these classes, respectively. Let
µ be the probability that a C0 mitochondrion acquires enough damage to transition into C1,
and assume that transitions occur when mitochondria replicate. We define the population
sizes of these classes as M0(t ) and M1(t ). To determine the impact of long-term mitochondrial
dynamics, we ignore transient plasticity and assume a constant population size K . Therefore,
K =M0(t )+M1(t ) for all time t .
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Figure 3.2. Schematic diagram for the mitochondrial selection model, which describes the
population dynamics of two mitochondrial classes (undamaged, C0; damaged, C1). Healthy
mitochondria can transfer to the damaged class with probability µ. Each class can replicate
or experience turnover with varying rates, which are defined to demonstrate the selective
differences between mitochondrial subpopulations. Each death is balanced by a birth, thus
maintaining a constant population size.
Let b0 and b1 be the respective growth rates for C0 and C1. Similarly, let the turnover rates
of these subpopulations be represented by d0 and d1. To incorporate the selective differences
between C0 and C1, let s denote the fractional growth reduction of damaged mitochondria and
c their fractional scavenging resistance. We then have
b1 = (1− s)b0, (3.1)
d1 = (1− c)d0. (3.2)
In this section, we utilize deterministic and stochastic methods to identify essential aspects of
mitochondrial dynamics within the cellular landscape.
3.1.1 The deterministic approach
We construct a system of continuous-time ordinary differential equations to illustrate the
dynamics of mitochondrial damage influenced by selection (Table 3.1, Equation (3.3)). The
combined turnover of the population is the sum of the individual processes, which occur at
rates proportional to the subpopulation sizes: d0M0 +d1M1. To ensure constant population
size, assume each turnover event is balanced by a growth event, as determined by the relative
growth rates of each population. Growth of the C0 population is contingent upon the failure to
transition to a damaged state, which occurs with probability (1−µ).
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Table 3.1. Parameter descriptions for Equations (3.3). A summary of all values used appears in
Table A.1.
Parameter Value/Range Units
K total population size mitochondria
µ damage transition probability #
s fractional growth deficit #
c fractional scavenging resistance #
b0 undamaged mitochondrial growth rate d
−1
d0 undamaged mitochondrial turnover rate d
−1
b1 damaged mitochondrial growth rate d
−1























We begin analysis of system (3.3) by defining pi(t ) = M0(t )
K
as the fraction of undamaged
mitochondria within a single cell. If this fraction is zero, we consider the cell to be in a state of






which has the equilibrium values





Stability analysis indicates that total damage of the skeletal muscle cell, that is, a population






which is the stability condition for pi∗1 . In terms of the selection parameter s and turnover factor
c, the condition for destruction of all healthy mitochondria is c > s−µ
1−µ . If µ¿ 1, then the
extinction requirement reduces to c > s. Thus, if the scavenging resistance of C1 mitochondria
is greater than the fitness penalty of damage, the system will favor total damage as t →∞.
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3.1.2 The stochastic approach
Individual mutation events, like the transitions fromC0 to C1, are rare and should be treated
stochastically. We develop a stochastic model to track the number of damaged mitochondria
in a cell. As in the deterministic system, we pair each turnover event with a growth event. The
probability that a death will be replaced by a birth in one of the classes depends on the relative
growth probability of either class, as in Equations (3.3). We can write a 2×3 transition matrix




= [a1 a2 a3]= [+1 −1 0−1 +1 0
]
, (3.7)
where ∆Mi is the change in the number of class i mitochondria (i = 0,1), and we can simplify
the accounting by explicitly including the possibility of no change.
We now define the probabilities associated with the transition events described in matrix
(3.7). Let pi = Pr(a1|M0 = i ) and qi = Pr(a2|M0 = i ). Then 1−pi − qi = Pr(a3|M0 = i ). Because
M0 +M1 = K , we may replace M1 with K −M0. As pi describes a gain of one in the healthy
mitochondrial population of size i and qi the equivalent loss, we can write
pi = d1(K − i )
d0i +d1(K − i )︸ ︷︷ ︸
death from C1
· (1−µ)b0i




d0i +d1(K − i )︸ ︷︷ ︸
death from C0
· µb0i +b1(K − i )
b0i +b1(K − i )︸ ︷︷ ︸
transition/birth to C1
, so that (3.9)
1−pi −qi = d1(K − i )
d0i +d1(K − i )︸ ︷︷ ︸
death from C1
· µb0i +b1(K − i )




d0i +d1(K − i )︸ ︷︷ ︸
death from C0
· (1−µ)b0i
b0i +b1(K − i )︸ ︷︷ ︸
birth to C0
.
Let pii (t ) represent the probability that there are i mitochondria in C0 at time t . Equiva-
lently, pii (t ) = Pr
(
M0(t ) = i
)
, which implies that 1−pii (t ) = Pr
(
M1(t ) = K − i
)
. We derive the
master equation describing the change in the probability distribution for the number of un-






= pˆi−1pii−1− (qˆi + pˆi )pii + qˆi+1pii+1, 16 i 6K −1,
dpiK
dt
= pˆK−1piK−1− qˆKpiK ,
(3.11)
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where pˆi = pi · [d0i + (K − i )]−1 and qˆi = qi · [d0i + (K − i )]−1 for events occurring, on average, at
the rate d0i + (K − i ). This has the stationary distribution pi∞0 = 1 and pi∞i = 0 for i 6= 0, provided
qK 6= 0. Hence, the only existing absorbing state in the stochastic framework is M0 = 0. This
result is in contrast to stability condition (3.6) of the deterministic model (3.3), which includes
a transcritical bifurcation.
3.1.2.1 Simulation
We implement a modified Gillespie algorithm (Appendix B) to simulate the mitochondrial
populations in the present model. Because the first damage transition occurs with such low
probability, there is an extended period of time over which very few changes occur, but beyond
which the selective advantage of damaged mitochondria leads to rapid fixation (Figure 3.3(a)).
Although it takes more than 500 years to initiate a substantial decline toward extinction, the
process is complete within three years (Figure 3.3(b)). We now wish to quantify the timing of
this process by determining the expected time to extinction of the undamaged population. We
consider this quantity to be the “time to total mitochondrial damage”.
3.1.2.2 Expected time to total mitochondrial damage
We reformulate the model as a modified version of the classical Gambler’s Ruin problem
to determine the expected extinction times. As before, let pi and qi denote the probabilities
of net gain and loss of one undamaged mitochondrion, respectively. Let Wi be the probability
that, beginning with M0 = i , M0 will equal K before it reaches zero. Necessarily, WK = µWK−1,
























































Figure 3.3. Representative trajectory for the number of undamaged mitochondria in the selec-
tion model (a) over several hundred years and (b) during the interval of rapid damage.
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because a C0-to-C1 transition, occurring with probability µ, is the only way damage can be
acquired in a completely healthy population of mitochondria. In the general case,
Wi = pi Wi+1+qi Wi−1. (3.12)
Let Li be the probability that all C0 mitochondria will be lost before reaching a size of K from
M0 = i . Using Equation (3.12), we obtain
Li = (1−pi −qi )+pi Li+1+qi Li−1. (3.13)
Now, let Ti be the expected time until the undamaged population meets its ruin from a popu-
lation of i mitochondria, and let Ei be the average duration of time between events. Because
turnover events dictate the net changes in the mitochondrial population,
Ei = [d0i +d1(K − i )]−1. (3.14)
If M0 remains unchanged, the new time to ruin is Ti +Ei . Similarly, the corresponding times
for a gain or loss in C0 are Ti+1+Ei and Ti−1+Ei , respectively. These lead to the second-order
difference equation
qi Ti−1− (pi +qi )Ti +pi Ti+1 =−Ei , (3.15)












, i = 1, . . . ,K −1,
TK = ηK +TK−1,
(3.16)
where ηi = Ei /qi , and ρi = pi /qi .
Figure 3.4 illustrates the mean extinction times for a variety of initial conditions. With K ini-
tially undamaged mitochondria, 602 years would pass, on average, before total damage occurs.
which applies to the time course shown in Figure 3.3. In a normally functioning individual,
this result suggests that although cellular health may decline over time, it does persist beyond
the duration of a lifetime. In an individual with metabolic abnormalities, a change in one or
more model parameters, such as µ, can reduce this time. A slight accumulation of damaged
mitochondria greatly reduces the time to total damage, emphasizing that the mean extinction
time is initially determined by slow transitions from C0 to C1.
To test the sensitivity of the total damage times to fractional growth reduction, s, and frac-
tional scavenging reduction, c, we evaluate the closed form solution (3.16) over the ranges
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Initially undamaged mitochondria (%)
Figure 3.4. Analytical solution to the modified Gambler’s Ruin problem for total damage times.
0 6 s 6 0.2 and 0 6 c 6 1 (Figure 3.5). If damaged mitochondria lack sufficient evasion from
scavenging mechanisms, reflected by c ¿ 1, the short-term selective advantage lies with un-
damaged mitochondria and extinction times range from Ti ∼O (104) to Ti >O (1050). In general,
if the deterministic stability criterion (c > s for µ¿ 1) is not satisfied for pi∗1 = 0, the correspond-
ing result in the stochastic model is an extremely large time to absorption.
3.1.2.3 Simulation and analysis comparison
We also use the extinction times from 2000 simulations to calculate the mean time to total
damage, comparing the result to that determined by the modified Gambler’s Ruin solution (Fig-





































Figure 3.5. Various TK from the stochastic mitochondrial selection model. Mean times to
extinction are plotted against scavenging reduction parameter c. Each curve corresponds a
particular growth reduction value s between 0 and 0.2.
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ure 3.6). Theoretical calculations produce a good approximation to the computational results.
There is a substantial difference between the mean and median extinction times for the upper
20% of undamaged mitochondria. This reflects significant variation in the damage acquisition
process, which can be explained by an exponential distribution of extinction times when the
initial population size is near maximal (Figure 3.7).
A small number of damaged mitochondria is equally as likely to undergo negative selection,
which would fully restore the healthy population of organelles, as to put selective pressure
on the undamaged subpopulation. Consequently, the survival advantage of C1 mitochondria
matches the replicative advantage of those in C0 when M0 ÀM1. Although healthy mitochon-
dria are more likely to grow, they are also more likely to die when their numbers are large.
Thus, initially, when healthy organelles dominate, very few changes occur in the population.
This adds considerable time to the extinction clock, but with a sudden shift in the balance,
selection favors the damaged class, and extinction proceeds rapidly.
3.2 The role of feedback
The effects of mitochondrial selection are slow compared to the dynamics of metabolism.
This, however, is only the case when feedback between these two entities is ignored. In this
section, we explore bidirectional feedback between intracellular mitochondrial population dy-
namics and intramitochondrial superoxide production.
3.2.1 Superoxide-to-mitochondrial damage feedback
Mitochondrial dysfunction by way of ROS perpetuates its own decline, yet the impact on
cellular function is not well defined. To address this, we create a feedback from our model of
superoxide production to that of mitochondrial selection. Specifically, we redefine the transi-
tion rate of a mitochondrion from C0 into C1 to be
µ(t )=µ0[1+ρ(Rs(t )/Rs0−1)]. (3.17)
The transition probability µ is assumed to increase linearly with superoxide so that at the
basal level (Rs = Rs0), a standard probability of µ0 applies. The slope ρ is therefore the ef-
fective strength of elevated superoxide in accelerating damage transitions. We assess the time-
dependent changes in extinction times (Equation (3.16)) by incorporating the dynamics of the
superoxide production model. As in Section 2.2, we seek to determine the impact of nutrient
intake marker ∆AUC on the present model. Figure 3.8 demonstrates reduced extinction times
with both time and ∆AUC. A value of ρ = 1 is used for all curves. The true effect of nutrient
29


























middle 50% of data
outer 50% of data
Figure 3.6. Simulation (white line) and analytical (black line) results for expected extinction
times of undamaged mitochondria (2000 simulations). Darker gray regions correspond to the
outer 50% of data, the lighter gray region to the middle 50% of data. 100% = 500 mitochondria.










Years to extinction from K mitochondria
Figure 3.7. Simulated distribution of extinction times from an entirely undamaged initial
population of K mitochondria. Results reveal an exponential distribution of times with rate
λ= 1/TK . K = 500.
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From 1 0% undamaged
mitochondria
(b)
Figure 3.8. (a) Time-varying profiles of total damage times, given different levels of nutrient
intake and a superoxide-dependent transition probability. (b) Extinction time trajectories for a
fully undamaged mitochondrial population. Both graphs cover an 80-year period with ρ = 1.
overload is to accelerate the extinction of C0 mitochondria (Figure 3.8(a)). In an entirely un-
damaged population of mitochondria, the times to total damage decrease as elevated superox-
ide concentrations increase the transition probability from healthy to damaged (Figure 3.8(b)).
Although the expected extinction times are longer for smaller values of ∆AUC, their reduction
over time is faster because of their dependence on 1/µ(t ). This analysis requires the compu-
tation of extinction times from a given number of healthy mitochondria. In continuous time,
however, damage and recovery occur non-discretely; this formulation does not independently
allow for continuous changes in superoxide-influenced mitochondrial population dynamics.
3.2.2 Bidirectional feedback
We extend our consideration of unidirectional feedback to account for the increased pro-
duction of superoxide by damaged mitochondria [50]. While selective differences are apparent,
it should also be true that inherent abnormalities in a damaged mitochondrion progressively
alter its function, further diminishing its capacity and efficiency for energy production and
other respiratory processes. In turn, this would lead to increased superoxide production.
Let D(t ) be the probability that any given mitochondrion is classified as damaged, ac-
cording to the stochastic model. Assume the effect of damage is to exacerbate mitochondrial
inefficiency. We define
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f (L,D)= (1−L)(1−D) (3.18)




= v2Ne ·kg i Gi (Ctot −C )−kc [(1−qr ) f (L,D)+qr ]C , (3.19)
Given that all mitochondria are assumed to develop inefficiency uniformly, we probabilistically
account for heterogeneity at the population level. f (L,D) therefore provides the link between
intramitochondrial processes and intracellular population dynamics, describing the condition
under which abnormalities within individual mitochondria are exacerbated by a damage sta-
tus.
We are equipped with information about the likelihood of damage, which allows for the
convenient treatment of intramitochondrial dynamics across multiple organelles, as well as
the stochastic population dynamics, which integrate an all-or-nothing response to the damage
of a single mitochondrion. The latter framework would require that we generate a total of
K superoxide subsystems to determine total cellular ROS production, whereas the former is
amenable to further changes in the model network. We therefore utilize the damage likelihood
approach to implement mitochondrial feedback on superoxide.
To derive the form of D(t ), we return to a master equation formulation of mitochondrial
damage and selection, in which we describe the evolution of the probability distribution for
the number of mitochondria in damaged class C1. Let p¯i j (t )= Pr(M1(t )= j ). Also, let p¯ j be the
rate describing a net loss of one damaged mitochondrion and q¯ j that of net gain. Formulations
of these expressions are similar to those previously used in (3.8) and (3.9), with the exception
that each probability evolves relative to the mean time [d0(K − j )+d1 j ]−1 between events:
p¯ j = d1 j · (1−µ)b0(K − j )
b0(K − j )+b1 j
(3.20)
q¯ j = d0(K − j ) · µb0(K − j )+b1 j
b0(K − j )+b1 j
. (3.21)
We incorporate superoxide-mediated feedback by assuming that µ is given by the time-dependent






= q¯i−1p¯ii−1− (q¯i + p¯i )p¯ii + p¯i+1p¯ii+1, 16 i 6K −1,
dp¯iK
dt






p¯i j . By definition, D = 1− p¯i0 and describes the probability of having at least one
damaged mitochondrion in the population. Given the simplicity of master equation (3.22), we
can solve this system with initial conditions p¯i0(0)= 1 and p¯i j (0)= 0 for j 6= 0. For ease of use, we
numerically solve these K+1 differential equations in conjunction with the superoxide produc-
tion model equations. Further, for constant µ, the dynamics of D do not change substantially
when solving a reduced version of the master equation comprising z +2 equations for z > 30






= q¯i−1p¯ii−1− (q¯i + p¯i )p¯ii + p¯i+1p¯ii+1, 16 i 6 z−1,
dp¯iz
dt
= qz−1p¯iz−1− (q¯z + p¯z )p¯iz
dp¯iK
dt
= q¯z p¯iz ,
(3.23)
The results presented henceforth are generated from the coupled superoxide system and the
truncated master equation (3.23). Because mitochondrial dynamics are progressive, we use
the original slow system (2.5h) in our coupling, and evolve all variables on the slow timescale.
Daily meals are then absorbed in a constant rate of nutrient intake σ. The solution curves in
Figure 3.10 are trajectories for superoxide concentration and total mitochondrial dysfunction
over 100 years. We define total dysfunction to be 1− f (L,D), which specifies the contribution
of both individual and population-wide effects to mitochondrial function.
As in the model without feedback, the present system reveals accelerated elevations in
superoxide concentrations with increased ∆AUC. However, the level of nutrient excess re-
quired for marked superoxide overproduction are reduced significantly. In the original model
(Figure 2.5), superoxide concentrations remain below 10−4 µM for the 120-year period with
∆AUC = 2.0. In Figure 3.11, on the other hand, this same value of ∆AUC forces superoxide
to rise well above 10−4 µM within 60 years. In addition, the inclusion of f (L,D) promotes
an age-related increase in oxidative stress independently of nutrient overload. This is illus-
trated by the superoxide curve associated with ∆AUC= 0, which experiences a slow rise. Total
mitochondrial dysfunction, as expected, progressively increases over time. Compared to the
timing predicted by the mean times to total damage, the feedback between superoxide and
mitochondrial damage accelerates the onset of catastrophe. Within the first two decades, there
is a relatively equivalent increase in dysfunction, due to the slow dynamics of L and D . As
the effect of growing superoxide takes hold, a separation develops, in which damage-mediated
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Figure 3.9. Comparison of truncated master equation pi0 trajectories. A total of z+2 equations
are used for each numerical solution shown. Because the mitochondrial population is assumed
to comprise K = 500 mitochondria, z 6 499 must be true. Curves in the right panel are
restricted to z > 30.















0.0 0.5 1.0 1.5 2.0
Figure 3.10. Dynamics of superoxide and mitochondrial dysfunction in the superoxide pro-
duction model with damage-mediated feedback.
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Figure 3.11. Mitochondrial dysfunction-superoxide phase plane summary of the model with
feedback. Total mitochondrial dysfunction is determined by the function 1− f (L,D). Filled,
black circles indicate 10-year increments, and dotted lines track these time points across vari-
ous ∆AUC.
feedback has a greater influence on ROS formation. In the end, it is unmitigated superoxide
levels that result in total organelle dysfunction.
We explore how the timing of such dysfunction is affected by two important parameters: ξ,
the rate at which mitochondrial inefficiency develops, and ρ, the effective strength of superox-
ide in damage acceleration. We choose these parameters because they are largely responsible
for the slow feedback that ultimately leads to complete mitochondrial damage. Physiological
levels of superoxide are between 10 and 200 pM [67]; as such, we construct age maps for super-
oxide concentrations exceeding an arbitrary threshold of 10−4 µM: ξ values span two orders of
magnitude from 0.1−10×10−6, ρ is varied within the closed interval [0,1], and ∆AUC= 0, 0.5,
1.0, 1.5 and 2.0. The full system is solved numerically for a period of 100 years, and we record
the year in which the threshold superoxide concentration is reached or exceeded (Figure 3.12).
For ∆AUC = 0, the threshold is surpassed within 100 years only when both ρ and ξ are
near their maximum values. As ∆AUC increases, the age to reach threshold decreases, falling
within a range of 30 – 40 years for more extreme values of ρ and ξ when ∆AUC = 2.0. These






















































Figure 3.12. Age maps indicating the interaction of the rate of mitochondrial inefficiency
development, ξ, and the strength of superoxide in increasing the mitochondrial transition
probability, ρ.
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tochondrial superoxide production, the worsening of such inefficiency due to mitochondrial
damage drastically reduces the time until mitochondrial capacity is overtaken by excessive
levels of superoxide.
3.3 Discussion
Our model of mitochondrial selection reveals important insights into mechanisms underly-
ing the progression of cellular dysfunction. Under the assumption that mitochondria expe-
rience baseline dysfunction, along with our consideration of characteristic population-level
differences arising from the damaged state, we determine that total mitochondrial damage is
favored within the cellular environment and that such damage develops over several years. In
the absence of distinct intracellular processes, these “years” refer to centuries; however, the
accumulation of reactive oxygen species in cellular organelles and the bidirectional positive
feedback between superoxide production and mitochondrial damage reduces this timeline to
the order of decades. We find that increased glucose load leads to considerable reductions in
the age to severe oxidative stress, as determined by threshold levels of mitochondrial superox-
ide.
In the full feedback model, we assume that superoxide affects the transition probability
from healthy to damaged mitochondria in a linearly decreasing fashion. Although the mech-
anism underlying this assumption is biologically more detailed, our model would require ad-
ditional variables that contribute unnecessary complexities. First, the progressive damage of
mitochondria can be dictated largely by oxidative stress levels, but the dynamic process under-
lying such a transition requires considerations of superoxide effects on mitochondrial mem-
brane potentials, along with the influx of water and other chemicals that can further alter
mitochondrial function. Second, complications arising from a compromised mitochondrial
membrane and other damage characteristics are necessarily linked to uniform mitochondrial
dysfunction (L), as the propensity toward further mutations continues to worsen mitochondrial
quality. Finally, mitochondrial fusion and fission events, more defined aspects of heteroplasmy,
and the resultant effect on mitophagy require a dynamical network describing the interactions
of individual entities and their characteristics. The mitochondrion is an entire biosystem on
its own, but given the multiple biological scales that contribute to the development of insulin
resistance, we eschew a systems biological approach in favor of identifying a few characteristic
factors that provide qualitative similarities.
In this chapter, we have described the impact of glucose on insulin resistance, based on
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the presence of oxidative stress and progressive mitochondrial dysfunction. Insulin resistance,
however, is defined by impaired insulin signaling, which is absent from this model. The pres-
ence of oxidative stress, accompanied by mitochondrial dysfunction should lead to defects in
the insulin signaling pathway, but we require a mechanistic basis for validation.
CHAPTER 4
THE PROGRESSION OF INSULIN RESISTANCE
Mitochondrial oxidative stress from nutrient overload is exacerbated by mitochondrial dam-
age. Insulin resistance is a localized protective mechanism in the short term, but its long-
term effects reach well beyond the individual cell, especially during the progression of type
2 diabetes. Insulin stimulates a series of phosphorylation events resulting in the activation or
inhibition of kinases downstream of its receptor, ultimately facilitating the entry of glucose into
target tissues. Insulin receptor substrates can be inhibited by stress-activated kinases, which
are themselves activated by oxidative stress or pro-inflammatory signals [94]. This inhibition
impairs the efficient propagation of the insulin signal and insulin-mediated glucose uptake.
In this chapter, we determine how the underlying changes in mitochondrial health affect the
progression of cellular insulin resistance through mathematical modeling (Figure 4.1).
The mechanisms explored in previous chapters for oxidative stress development and cel-
lular dysfunction converge on the progression of insulin resistance through the insulin sig-
naling pathway. Upon insulin binding to its receptor, the receptor tyrosine kinase becomes
activated, leading to the immediate phosphorylation of insulin receptor substrate 1 (IRS-1)
on tyrosine residues [20, 101]. This protein then associates with and subsequently activates
the p85 regulatory subunit of phosphatidylinositol 3-kinase (PI3K). PI3K activation allows for
the generation of phosphatidylinositol (3,4,5) trisphosphate, which leads to Akt/protein kinase
B (PKB) activation. PKB is arguably a hub in insulin signaling, as it regulates a plethora of
insulin-stimulated activities, including protein synthesis, glycogen synthesis for glucose stor-
age, and cell survival [91]. The kinase also facilitates the translocation of glucose transporter 4
(GLUT4) to the cellular membrane via phosphorylation of Akt substrate 160, thus allowing for
cellular glucose entry (Figure 4.2). The ability of skeletal muscle cells to remove glucose from
the plasma therefore depends directly on the presence of GLUT4 at their surface, and insulin
can increase the number of these when necessary [25, 55, 87, 91].
Hydrogen peroxide is a detoxified form of superoxide, but unlike superoxide, can leave the
mitochondrion where it is produced and diffuse into the cytosol [67]. There, it activates stress
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Figure 4.1. Illustration of the primary focus of Chapter 4. Feedback between superoxide
production and mitochondrial damage, in the presence of nutrient excess, promotes elevated
cytosolic hydrogen peroxide insulin resistance. O·−2 : superoxide; H2O2: hydrogen peroxide.
Figure 4.2. Insulin signaling overview. IRS-1 is tyrosine phosphorylated upon insulin binding
to its receptor, leading to PI3K and PIP3 activation. Downstream activation of PKB leads to
GLUT4 exocytosis via protein AS160. IRS-1: insulin receptor substrate-1; Py: tyrosine phospho-
rylation; PI3K: phosphatidylinositol 3-kinase; PIP2: phosphatidylinositol (4,5) bisphosphate;
PIP3: phosphatidylinositol (3,4,5) trisphosphate; PKB: Akt/protein kinase B.
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protein c-Jun N-terminal kinase (JNK) in a dose-dependent manner [104]. One target of JNK
is IRS-1, where it phosphorylates serine residues. Serine phosphorylation inhibits the tyrosine
phosphorylation of IRS-1 that is required for proper post-receptor signaling [2,20]. Excess food
intake and elevated insulin lead to increased glucose uptake and in turn to cellular oxidative
stress. The resulting JNK activation impairs insulin signaling, with the effect of reducing both
the amount of glucose entering the cell and oxidative stress. Accumulated reactive oxygen
species in skeletal muscle cells therefore create a protective negative feedback loop [43].
4.1 Model of insulin signaling
We define a minimal model of insulin signaling that quantifies the effects of oxidative stress.
Sedaghat et al. provide a detailed mechanistic model for insulin signaling that tracks the insulin
signaling cascade, from surface receptors to several downstream kinases [85]. An input of
insulin eventually results in the movement of intracellular GLUT4 to the cell membrane for
glucose uptake. This model does not include the inhibitory function of serine-phosphorylated
IRS-1.
Nyman et al. use in vitro data and current knowledge of metabolic regulation to develop a
comprehensive systems biological model of glucose homeostasis with three major subsystems:
whole-body, adipose tissue signaling, and insulin binding [71]. The purpose of the full model is
to test hypotheses that provide a link between in vitro and in vivo experimentation, in order to
ultimately explain observed differences in adipose tissue glucose uptake data. This model does
include the inhibitory function of IRS-1 serine phosphorylation. However, the mechanism of
this activity is different for adipocytes, wherein mammalian target of rapamycin (mTOR) is the
major cause of serine phosphorylation. mTOR is a downstream target of PKB, and its effect in
adipose tissue does not alter mitochondrial function [42].
We aim to elucidate the mechanisms contributing to the long-term progression of insulin
resistance in skeletal muscle cells by developing a minimal version of the Sedaghat et al. model,
in the same vein as the adipose tissue module of the Nyman et al. M 2 model. In our model, ox-
idative stress-activated proteins, influenced by intra-mitochondrial dynamics, are responsible
for the negative feedback of IRS-1 serine phosphorylation on insulin signaling (Figure 4.3).
The full system (4.1) consists of 11 ordinary differential equations. The model’s state vari-
ables are fractions of unbound and bound insulin receptors, Iu(t ) and Ir (t ); activity level of
phosphorylated tyrosine residues within IRS-1, Py ; activity level of phosphorylated inhibitory
serine residues within IRS-1, Ps(t ); unphosphorylated and phosphorylated JNK, Ju(t ) and J (t );
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Figure 4.3. Insulin signaling pathway with reactive oxygen species effects. Insulin stimulates
tyrosine phosphorylation of IRS-1, which leads to PKB activation and subsequent GLUT4
translocation to the cell membrane. Glucose enters the cell through these transporters, and
its metabolism generates superoxide, which leads to the presence of hydrogen peroxide in the
cytosolic space. Hydrogen peroxide activates JNK, which leads to IRS-1 serine phosphoryla-
tion. The phosphorylated serine residues prevent tyrosine phosphorylation, thus impeding the
insulin signal. IRS-1: insulin receptor substrate-1; Py: tyrosine phosphorylation; Ps: serine
phosphorylation; PKB: Akt/protein kinase B; JNK: c-Jun N-terminal kinase; H2O2: hydrogen
peroxide; O·−2 : superoxide; GLUT4: glucose transporter 4.
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unphosphorylated and phosphorylated PKB, Pi (t ) and P (t ); fractions of intracellular and mem-
















































= qhK ·αh(As ,Rs)−δr h AhRh (4.1g)
With a detailed description of the model, we apply a number of simplifications to reduce
the number of equations in (4.1) from 11 to 4.
• Insulin receptors. By applying conservation laws of time-scale arguments, we assume
that insulin receptor activation is an immediate first step in the insulin signaling cascade
(Equations (4.1a)). The rate at which insulin binds its receptor is governed by mass-
action kinetics, with a linear unbinding term. No insulin is removed from the plasma
during this process, and we assume that the level of insulin, I , remains constant. We
assume that synthesis and degradation of insulin receptors are balanced, so that the
total number of insulin receptors is constant. Thus, we can model the fraction of bound
insulin receptors only as
dIr
dt
=αi (1− Ir )I −δi Ir . (4.2)
• IRS-1 phosphorylation dynamics. We assume that tyrosine phosphorylation in IRS-1 de-
scribes the activation level of IRS-1, while serine phosphorylation defines the level of
inhibition of IRS-1. In both cases, a maximal activity level of 1.0 is assumed. Thus,
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downstream insulin signaling occurs at a rate proportional to the level of tyrosine activity,
modulated by serine inhibition (Equation (4.1b)). Because post-receptor activation of
tyrosine IRS-1 is immediate, we take the proportion of bound insulin receptors to be in
quasi-steady state, yielding the expression











(1−Py )P us −δy Py . (4.4)
Inhibitory serine sites are phosphorylated at a rate linearly proportional to JNK activ-
ity, and serine deactivation occurs at constant rate δs (Equation (4.1c)).
• JNK dynamics. In Equations (4.1d), JNK activation via hydrogen peroxide is assumed to
decay in the absence of its stimulus, while Jmax = Ju + J is the constant maximal level of
JNK activity. With Ju = Jmax− J , JNK signaling dynamics are given by
dJ
dt
=α j (Jmax− J )Rh −δ j J . (4.5)
By assuming that the effect of hydrogen peroxide is seen immediately in the elevation








where jˆ = δ j /α j , as the response curve of JNK to hydrogen peroxide.
• PKB/Akt dynamics. The effect of upstream cascade components on PKB phosphoryla-
tion is assumed to be proportional to IRS-1 tyrosine phosphorylation (Equations (4.1e)).
Under the assumption that Pi +P = 1, Pi = 1−P , and we obtain
dP
dt
=αp Py (1−P )−δp P. (4.7)
By further assuming an instantaneous effect of tyrosine phosphorylation on GLUT4 translo-
cation, we describe changes in total PKB activity with





with pˆ = δp /αp .
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• GLUT4 dynamics. GLUT4 synthesis and degradation are assumed to balance, so that the
total GLUT4 concentration, comprising both membrane and intracellular transporters,
is constant. Hence, we denote the fraction of transporters in either location by Ui and
U , so that Ui +U = 1. Transporters regularly cycle between intracellular and membrane
states, while the function of PKB is to further stimulate the movement of GLUT4 toward
the cellular membrane. We replace the equations in (4.1f) with
dU
dt
= (αu +ηuP )(1−U )−δuU . (4.9)
• Hydrogen peroxide dynamics. A fraction qh of superoxide-derived hydrogen peroxide
diffuses from mitochondria into the cytosol (Equation (4.1g)). Because the superoxide
concentration is assumed to be the same in all mitochondria, the total contribution to
cytosolic hydrogen peroxide must be multiplied by the total mitochondrial population
size, K . αh(As ,Rs) represents the MnSOD-dependent dismutation rate of superoxide, and
catalase-mediated hydrogen peroxide removal is assumed to be the constant δr h Ah .
4.1.1 Model reduction
Based on the above simplifications, we model the dynamics of insulin signaling and oxida-


























=qhK ·αh(As ,Rs)−δr h AhRh (4.10d)
This system has two inputs: insulin and hydrogen peroxide. We assess the composite effects
of these by first computing the steady-state percentage of membrane GLUT4. The equilibrium





Ps = αs JmaxRh




[αy (1−Ps)Ir +δy ](I + Ih)
(4.13)
U = αu(Py + pˆ)+ηp Py
(αu +δu)(Py + pˆ)+ηp Py
(4.14)
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αs serine phosphorylation min
−1
αu basal GLUT4 translocation min
−1
αy tyrosine phosphorylation min
−1
δr h hydrogen peroxide removal µM
−1 min−1
δs serine dephosphorylation min
−1
δu GLUT4 internalization min
−1
δy tyrosine dephosphorylation min
−1
ηp PKB-mediated GLUT4 translocation min
−1
Ih half-maximal insulin activity pM
jˆ half-maximal JNK activation µM
Jmax maximal JNK activity #
K total number of mitochondria mitochondria
pˆ half-maximal PKB activity #
qh fractional cytosolic appearance of hydrogen peroxide #
Combining Equations (4.11) – (4.14) yields a function U (I ,αh), for which we can create a
contour plot (Figure 4.4). Insulin enhances the percentage of GLUT4 at the cell membrane,
while hydrogen peroxide has the opposite effect. Elevated insulin partially reverses the inhi-
bition that oxidative stress imposes on glucose uptake, but the effectiveness of such action
varies. For lower hydrogen peroxide production rates, insulin compensates well, as determined
by the net gain in GLUT4 over all insulin concentrations. For intermediate levels of production,
this compensation reaches a maximum, which then declines toward near-basal effect sizes
for higher production. These results suggest that sufficient β-cell compensation for insulin
resistance can maintain normal glucose regulation, but that an inability of β cells to do this
leads to an oxidative stress-mediated loss in glucose uptake capacity.
4.1.2 Summary
Our model of insulin signaling incorporates essential aspects of the insulin signaling path-
way, along with inhibitory mechanisms that play a role in the progression of insulin resistance.
Through equilibrium analysis, we have demonstrated a mechanism through which hydrogen
peroxide originating from mitochondria reduces the ability of skeletal muscle cells to respond
to insulin cues. We conclude that an elevation in superoxide production ultimately impedes
post-receptor insulin signaling through the activation of intracellular stress signaling.
Of note are some biological factors that have been omitted from our model, such as obe-
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Figure 4.4. Steady-state percentages of membrane GLUT4 presence in response to insulin and
hydrogen peroxide from the reduced insulin signaling model. The lowest H2O2 production rate
shown is 0 per mitochondrion min−1; the highest rate is 100.0 per mitochondrion min−1.
sity. Insulin resistance and obesity occur together frequently in a clinical setting and reveal
a role for inflammation in metabolic abnormalities [66]. In skeletal muscle tissue, along with
adipose tissue, inflammatory signals, especially tumor necrosis factor α (TNFα), have been
implicated in JNK activation [45]. The convergence of reactive oxygen species and inflamma-
tion on stress activation in skeletal muscle cells eliminates the need for an explicit description
of diet-induced inflammation. A long-term state of obesity can be modeled by an external
environmental parameter that increases JNK-mediated serine phosphorylation independently
of hydrogen peroxide. Inclusion of an inflammatory factor would therefore work to further
inhibit tyrosine phosphorylation and decrease membrane GLUT4.
Several components of the insulin signaling cascade have also been left out of the model,
in contrast to the the work of Sedaghat et al. [85]; however, this omission reflects the goal of
the present work. The activity of cellular reactive oxygen species interrupts normal insulin
signaling, while insulin stimulates it. This framework allows us to incorporate additional time-
dependent components that contribute to a mechanistic timeline of metabolic dysregulation,
while limiting superfluous levels of complexity.
4.2 Model of insulin resistance
The story of insulin resistance begins in the plasma, migrates to the mitochondrion and
continues into the cytosol, where the insulin signaling pathway lies. In this section, we com-
47
bine the models of superoxide production and insulin signaling from Chapter 2, the damage
feedback model described in Chapter 3, and the reduced model of insulin signaling outlined in
Section 4.1. The combined model studies the role of mitochondria and nutrient excess in the
progression of insulin resistance.
To explicitly model insulin signaling as the primary mechanism of insulin-stimulated glu-
cose uptake, we must also modify the original glucose-insulin subsystem (2.1). Under the
assumption that insulin-mediated glucose uptake is proportional to the fraction of GLUT4 (U )
at the plasma membrane in skeletal muscle cells, we obtain the revised subsystem in Equa-
tions (4.15a) – (4.15c). The primary difference is that in Equation (4.15a), total glucose uptake
is given by sˆGU , which contrasts the earlier representation in Equation (2.1b) of SG I . With
mitochondrial and reactive oxygen species dynamics, Equations (4.15d) – (4.15n) complete the
system.
We augment superoxide dynamics with spontaneous dismutation, given by the term δr sR
2
s
(Equation (4.15e)). MnSOD function is extremely effective, and the rate of dismutation via
this antioxidant is several orders of magnitude faster than that brought on by the collision of
two superoxide anions [34]. Thus, spontaneous dismutation becomes significant in governing
hydrogen peroxide dynamics only upon MnSOD depletion. Once As = 0, superoxide and hy-
drogen peroxide approach their respective equilibrium concentrations, which are identical for
all ∆AUC, and the difference between health and dysfunction is determined by the times at
which these equilibria are approached, as is the case in the previous formulation.
We initialize the system by assuming that glucose is in equilibrium according to the given
value of food intake parameter σ, which is held constant for the duration of the simulated time
courses. We then solve for sˆ in
dG
dt
=σ+hg −kg G− sˆGU
according to the initial steady-state assumption, so that sˆ = (σ+hg − kg G0)/(G0U0). sˆ is an
adapted rate of uptake into skeletal muscle cells determined by exogenous glucose input. In
each case, G(0) = 5 mM. Trajectories for plasma glucose and insulin, hydrogen peroxide, both
IRS-1 phosphorylation states, and membrane GLUT4 are presented for several values of ∆AUC
between 0 and 4.0 with ρ = 0.5 (Figure 4.5).
∆AUC > 0 leads to elevated glucose uptake rates from plasma into the cell. As a result,
glucose, insulin, and serine phosphorylation activity experience larger rates of increase, over-
coming the fact that each of these variables has the same initial condition for every ∆AUC
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=q¯i−1p¯ii−1− (q¯i + p¯i )p¯ii + p¯i+1p¯ii+1, (4.15j)
with p¯ j = d1 j · (1−µ(t ))b0(K − j )
b0(K − j )+b1 j
,
q¯ j = d0(K − j ) · µ(t )b0(K − j )+b1 j
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Figure 4.5. Trajectories from the superoxide production model with insulin signaling and
mitochondrial damage feedback. ρ = 0.5.
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tochondrial function, and increases in hydrogen peroxide and serine phosphorylation of IRS-1
are met with decreases in tyrosine phosphorylation and membrane GLUT4. Upon maximal
mitochondrial dysfunction (a value of 1.0), a shift in the cytosolic variables is seen. Glucose,
insulin, and IRS-1 serine phosphorylation increase at even greater rates; hydrogen peroxide
reaches its maximal steady-state concentration; and, the percentage of GLUT4 at the cellular
membrane experiences a sharper decline. Nutrient excess facilitates a more dramatic change
in these variables and greatly reduces the timing of major dysfunction.
For ∆AUC = 0, worsening mitochondrial function, due to either age-related or damage-
mediated inefficiency, is the major cause of the slight decline in metabolic function. For ∆AUC>
0, elevated concentrations of glucose result in higher insulin levels, which allow for a pro-
portional rise in uptake via increased tyrosine phosphorylation, more hydrogen peroxide and
subsequent metabolic abnormalities. In all cases, the total rate at which glucose is taken into
skeletal muscle cells remains constant.
Complete mitochondrial dysfunction initiates a break point in the system, beyond which
model dynamics experience more rapid changes. This behavior is in line with the longitudinal
data analysis by Tabák et al., in which type 2 diabetics exhibit an elevated rate of decline in
insulin sensitivity shortly before disease diagnosis [90]. By extending the time interval of our
numerical solutions, we can determine the timing of the break point in model dynamics for
a range of ∆AUC (Figure 4.6). The timing of these sharp changes in metabolic activity are
inversely proportional to ∆AUC. Oxidative stress, combined with nutrient excess, therefore
plays a significant role in the decline of skeletal muscle function over time. Yet, even in the
absence of glucose overload, total mitochondrial damage occurs within fewer than 200 years,
which is a substantial reduction from the 602-year estimate from the original mitochondrial























Figure 4.6. Timing of the transition to total mitochondrial damage over a range of ∆AUC.
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selection model (Chapter 3). This suggests that an unavoidable accumulation of ROS and
progressive alterations to mitochondrial health, however slight, are important in metabolic
regulation.
4.3 Discussion
We have developed a minimal model of insulin signaling subject to ROS-induced modifica-
tion. Environmental changes that increase mitochondrial superoxide production also increase
cytosolic hydrogen peroxide. The result is oxidative stress-mediated activation of JNK, which
impairs proper insulin signaling through inhibitory phosphorylation of the insulin receptor
substrate.
Insulin signaling experiences some level of impairment through the course of the average
lifetime. The free radical theory of aging asserts that this change is due to the development
oxidative stress with age [98]. The results of the present model are consistent with this no-
tion, as the GLUT4 trajectory for ∆AUC = 0 demonstrates an age-related decline that occurs
independently of environmental factors. Inherent changes in mitochondrial health promote
superoxide production, and as the likelihood of cellular mitochondrial dysfunction increases,
so too does the likelihood of oxidative stress. Hydrogen peroxide derived from the decline
in mitochondrial health leads to small stress responses that enhance serine phosphorylation
of IRS-1, thus reducing GLUT4 at the plasma membrane. Hence, external factors, such as
excess diet-derived glucose, exacerbate age-related insulin resistance through oxidative stress-
mediated mitochondrial damage and impaired insulin signaling.
Initially, plasma glucose levels rise because of the slow decline in membrane GLUT4.
Glucose-stimulated insulin secretion is sufficient to maintain constant levels of glucose uptake
given a reduction of transporters at the cell surface (Figure 4.5). However, the initial rise in
glucose due to ∆AUC input is not properly regulated by the current system. This is because
the current system does not mount a compensatory response to glucose concentrations above
“normal” steady-state levels. The existing compensation is the result of the standard insulin
secretory response based on β-cell glucose sensing, which has a half-maximal stimulatory con-
centration (Gh) of 9.0 mM. The largest concentrations reached in the current model barely
exceed 5.3 mM, so that insulin increases approximately linearly with glucose for the 100-year
period of interest. Were sufficient compensatory β-cell function a factor in this model, the
elevations in insulin would be more substantial. Therefore, the progression of a noticeably
defective response to insulin requires not only the existence of inherent or environmentally-
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influenced metabolic abnormalities, but also mechanisms that can improve the situation in
the short term, but cause more harm than good in the long term. This is the role of β cells
in the progression of insulin resistance and in the development of type 2 diabetes, which also
explains why insulin resistance alone does not cause diabetes [7, 66].
CHAPTER 5
β-CELL FUNCTION AND DECOMPENSATION
β cells are solely responsible for the prevention of hyperglycemia. Dysfunction in periph-
eral tissues cannot lead to type 2 diabetes in the absence of β-cell abnormalities. Mechanisms
of β-cell failure, as in the progression of insulin resistance, are incompletely understood. Well-
defined, however, are the factors affected by such failure. β-cell activity encompasses three
major components: β-cell mass, insulin secretion and insulin biosynthesis. Each of these has
the capacity to adapt to changing metabolic demands, and a β-cell population that is unable
to meet the requirements is considered dysfunctional. Sufficient loss of function results in the
relative insulin deficiency that precipitates type 2 diabetes [66, 81].
To elucidate the mechanisms underlying β-cell failure, it is important to identify which
components contribute the most dysfunction. Substantial reductions in β-cell mass have been
associated with type 2 diabetes; specifically, the rates of apoptosis in these cells are increased
[40,66,100]. However, only pancreatectomies resulting in the removal of more than 80% of nor-
mal β-cell mass result in insulin deficiency [26]. Further, it is unclear whether type 2 diabetics
exhibit significant β-cell loss at the time of diagnosis [22, 63]. Together, these findings suggest
that defective insulin synthesis and secretion contribute primarily to the onset of β-cell failure,
while β-cell loss is a secondary defect.
Glucose-sensing in β cells is the primary signal for insulin secretion and occurs in two
phases. The first phase is completed within 10 minutes of intravenous glucose stimulation [25],
whereas the second may last for hours [48, 66]. Upon glucose entry into the β-cell, glucose
phosphorylation, the first step in the glycolytic pathway, determines the rate at which glycolysis
proceeds [46, 70, 72]. Glycolytic pyruvate increases the cytosolic ATP/ADP ratio through oxida-
tive phosphorylation, precipitating the closure of ATP-dependent potassium channels (KATP).
Cell depolarization and activation of voltage-gated calcium channels follow, thereby increasing
the concentration of intracellular calcium. This rise in calcium promotes insulin exocytosis
from secretory granules at the β-cell surface and thus a rise in circulating insulin [39, 86].
Glucose-stimulated KATP-dependent exocytosis characterizes the first phase of insulin secretion
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[101]. A KATP-independent pathway amplifies the initial secretory and biosynthetic response,
thus characterizing the second phase of insulin release, in which the exocytosis of existing
hormone stores and the production of new insulin occurs. About half of all pyruvate generated
by glycolysis enters this alternate pathway of cycling, from which amplifying signals, such as
NADPH and α-ketoglutarate, are generated [46, 66]. These additional metabolites allow for
constitutive glucose regulation.
Whereas the mitochondrion is largely responsible for immediate insulin release, the endo-
plasmic reticulum (ER) of β cells is a hub for proper insulin processing that leads to storage
and exocytosis. Preproinsulin, the downstream product of insulin gene transcription, migrates
to the ER membrane from the cytoplasm, and cleavage of its translocation signaling peptide
accompanies its entry into the ER lumen. Upon entry, the immediate insulin precursor, proin-
sulin, is generated in its unfolded form. The ER folding machinery is responsible for processing
nascent proinsulin in preparation for transit to the Golgi apparatus and subsequent packaging
via granule synthesis [57]. Insulin release from the endocrine pancreas therefore relies on the
interplay of several processes, whose proper function is necessary to prevent insulin insuffi-
ciency and glucose dysregulation.
ER stress results from an increased need for insulin and can impair β-cell function. It is
characterized by an imbalance between the ER folding load and folding capacity [7]. High
insulin demand increases the ER proinsulin processing workload and the likelihood of im-
proper folding. Under these circumstances, the influx of unfolded proteins can overwhelm
the ER folding mechanism, while an accumulation of unfolded or misfolded proteins triggers
the unfolded protein response (UPR) of the cell. This response serves several important func-
tions: It increases the folding capacity through ER-assisted folding (ERAF); it increases the
degradation of misfolded and unfolded proteins through ER-associated degradation (ERAD);
it reduces general protein translation in the cell; and, it upregulates transcription of its own
genes [62, 103].
There are three primary effectors of the UPR: protein kinase RNA-like endoplasmic reticu-
lum kinase (PERK), inositol-requiring protein 1α (IRE1α), and activating transcription factor 6
(ATF6) (Figure 5.1). Each of these is inhibited when bound to the ER chaperone immunoglob-
ulin binding protein (BiP) [7, 33]. In the presence of ER stress, unfolded proteins sequester BiP,
which allows for UPR effector activation. PERK attenuates protein translation by phosphorylat-
ing the α subunit of eukaryotic initiation factor 2; IRE1α and ATF6 phosphorylate and activate
X-box binding protein 1 (XBP1) mRNA, which leads to increased transcription of UPR genes,
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Figure 5.1. Unfolded protein response in an ER stress setting. In the absence of ER stress, BiP
inhibits UPR effectors ATF6, IRE1α, and PERK through binding. An accumulation of unfolded
proteins in the ER lumen sequesters BiP, allowing for UPR activation. In this case, PERK initi-
ates eIF2α phosphorylation, which promotes attenuation of protein translation within the cell,
thus reducing the workload sent to the ER. ATF6 and IRE1α both promote the production of
ER chaperones and genes for ERAF and ERAD. The dotted line indicates that XBP1 is one target
of ATF6, which can also undergo cleavage that results in similar ER stress-related responses as
XBP1. ATF6, activating transcription factor 6; BiP, immunoglobulin binding protein; eIF2α-P,
phosphorylated α subunit of eukaryotic initiation factor 2; ERAD, ER-associated degradation;
ERAF, ER-assisted folding; IRE1α, inositol-requiring protein 1α; PERK, PKR-like endoplasmic
reticulum kinase; XBP1, X-box binding protein 1.
BiP, and other essential ER chaperones [41, 97, 103].
Various chaperones mediate ERAF and ERAD activity, while also inhibiting the UPR. To
enhance ERAF and ERAD responses, the UPR effectively upregulates production of the chap-
erones, creating a negative feedback loop that allows the system to reset once the stress has
been eliminated [54, 97]. In a constitutively stressed ER, UPR activity can cause a progres-
sive decline in insulin output through attenuated protein, and hence proinsulin, translation,
which may contribute to the relative insulin deficiency accompanying type 2 diabetes onset.
Further, when the severity of ER stress creates a permanent imbalance between workload and
processing, prolonged UPR activation can initiate proapoptotic pathways, resulting in β-cell
death [5, 56, 66].
In this chapter, we present a mathematical model for β-cell function and explore mech-
anisms of dysfunction through the UPR and β-cell compensatory mechanisms. Section 5.1
contains a model of the UPR and insulin production with constant β-cell mass, which we use
to assess the effects of glucose on short-term UPR induction. In Section 5.2, we incorporate
β-cell mass dynamics in a larger framework of glucose regulation to determine the long-term
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implications of nutrient excess and insulin resistance.
5.1 Model of β-cell function
Following the framework of Trusina et al. [97], we construct a mathematical model of in-
tracellular β-cell function based on unfolded proteins. The purpose of the original model
is to determine the impact of UPR-mediated protein translation attenuation in relieving ER
stress, as determined by increased production of unfolded proteins. Also explored is the relative
benefit of reduced translation to the cell as a function of the duration of externally applied
pulsatile stress. We adapt this model to incorporate the effects of glucose on β-cell insulin
production and release, under the assumption that attenuated protein translation is a feature
of the UPR (Equations (5.1), Figure 5.2, Table 5.1). State variables include unfolded proin-
sulin protein, Buu(t ); XBP1 mRNA, Bux (t ); ER chaperone proteins, Buc (t ); and folded insulin
protein, Bu f (t ). The primary modifications of the Trusina et al. model are the inclusion of the
glucose-dependent term in Equation (5.1a) and the addition of (5.1d) to describe the fate of
folded insulin. We also include plasma glucose and insulin dynamics, but not detailed skeletal
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=hˆi B ·ku f GBu f −ki I , (5.1f)







• Unfolded proinsulin. Proinsulin production is stimulated by glucose in a sigmoidal man-
ner [84], and the activity of UPR component PERK reduces this production (Equation
(5.1a)). PERK is activated by newly synthesized proinsulin and is inhibited by a general
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Figure 5.2. Model of β-cell function. Glucose stimulates proinsulin production and the se-
cretion of stored, properly folded insulin into the plasma for glucose regulation. Unfolded
proinsulin activates the UPR, which can carry out functions associated with either PERK or
IRE1α. PERK-mediated action results in the attenuation of proinsulin translation, while IRE1α-
dependent responses activate XBP1 mRNA to promote chaperone production. These chaper-
ones are essential in the folding and degradation of proinsulin and also serve to negatively
regulate UPR induction.
Table 5.1. Parameter descriptions for Equations (5.1). A summary of all values used appears in
Table A.1.
Parameter Value/Range Units
duc chaperone decay min
−1
duu proinsulin folding/degradation min
−1
dux XBP1 mRNA decay min
−1
hˆi plasma conversion factor pM molecule
−1 (106 cells)−1
huc XBP1-dependent chaperone production molecules (mRNA level)
−1 min−1
huu proinsulin production molecules min
−1
hux IRE1α-induced XBP1 mRNA activation mRNA level min
−1
KPERK maximal PERK activity #














qu f proinsulin folding fraction mM
−1 min−1
σuc basal chaperone production molecules min
−1
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class of ER chaperones, Buc , according to Michaelis-Menten kinetics. Buc removes proin-
sulin via folding and degradation, which are combined into a single term. We assume
that misfolded proinsulin results in immediate degradation and that β-cell turnover, oc-
curring on the order of months [78], does not have a significant impact on the presence
of ER proinsulin.
• XBP1 activity. IRE1α is assumed to follow the same Michaelis-Menten kinetics as PERK,
and its maximal activity level is absorbed in the production rate of active XBP1 mRNA
(Equation (5.1b)). First-order degradation of active XBP1 mRNA occurs at rate dux . We
use arbitrary units to describe mRNA levels.
• ER chaperones. ER chaperones are generated at a constant rate and undergo first-order
degradation (Equation (5.1c)). XBP1 provides an additional source of chaperones through
mRNA-mediated translation upregulation.
• Folded insulin. A fraction qu f of removed proinsulin is assumed to be folded, thus enter-
ing the intracellular insulin compartment, which comprises both immediately accessible
and stored insulin (Equation (5.1d)). We assume that the process of folded hormone
transport to the Golgi apparatus and subsequent granule biosynthesis is immediate and
that glucose leads directly to the release of insulin from this pool into the plasma.
• Plasma. Plasma glucose appears from exogenous (σ) and hepatic (hg ) sources and is
removed by insulin-dependent and -independent means (Equation (5.1e)). We assume a
constant number of β cells, B , and each of these is assumed to secrete an average amount
ku f GBu f of insulin protein, which is converted to plasma concentrations with factor hˆi
(Equation (5.1f)). First-order kinetics govern insulin clearance from the blood.
5.1.1 Response to daily meals
To assess the feedback dynamics within the UPR submodel, we solve the differential equa-
tions with a square wave food intake parameter, σ, defined in terms of the average daily change
in the glucose area under the curve, ∆AUC. Results shown in Figure 5.3 correspond to ∆AUC=
1. Because PERK and IRE1α responses are induced identically, we describe overall UPR effector
activity with uˆ and discuss its differential effects with respect to the present simulation. At
the onset of the first meal (M1), all variables, save the chaperones and folded insulin, rise
rapidly. ER chaperones experience a delayed increase, while the insulin protein level within the






































































































































































































































































































in proinsulin and consequently in UPR activity. For the duration of M1, intracellular insulin
content declines substantially due to the required increase in insulin secretion. This leads to
elevated plasma insulin, which peaks shortly after the conclusion of M1. XBP1 production
tracks the dynamics of IRE1α-mediated UPR activity, achieving a local maximum after peak
UPR induction. ER chaperone proteins follow suit, as they respond to activated XBP1 mRNA.
Recovery of insulin protein in the β-cell occurs after the peak in proinsulin production and
the folding activity of chaperones. Prior to the start of M2, no variable returns to its basal
level. More dramatic differences from baseline are apparent in proinsulin, insulin protein,
glucose, and chaperone proteins. Slow decay of chaperones influences the continued decrease
in proinsulin and concurrent rise in folded insulin, but the delayed peak prevents restoration
of basal activity before the beginning of M2.
Because ER chaperones remain elevated, when the glucose concentration begins its second
rise, a greater maximal chaperone amount is achieved, but with a smaller net change. This is
precipitated by an XBP1 response that is also smaller in amplitude than the response mounted
with M1, likely due to the reduced change in proinsulin. As with glucose, proinsulin does not
decay to baseline in the inter-meal period from M1 to M2. However, the ability of β cells to
generate a sufficient insulin response is due to the continued presence of elevated chaperones,
which reduce UPR activity and consequent protein attenuation, yet promote insulin folding.
Maximal XBP1 mRNA levels are lower than with M1, which reduces the net gain in ER chaper-
ones. Nevertheless, the higher peak in chaperone number allows plasma insulin production to
remain intact.
Responses to M3 closely resemble those of M2, with the exception that the 12-hour period
without meals after M3 gives the system more opportunity to return to a basal state. However,
the perturbations in glucose appearance are too large to achieve full restoration of the original
state; this indicates a slight desensitization of regulatory responses, which is reflected in the
deviation of each quantity from its basal level just before the onset of the next meal at hour 30.
We also detail model behavior over a period of three days, for integer values of ∆AUC be-
tween 0 and 4.0. (Figure 5.4). Higher levels of nutrient intake increase all components of β-cell
function, namely proinsulin, XBP1 mRNA, and ER chaperones. The decrease in insulin pro-
tein levels with elevated ∆AUC indicates heightened secretory function within individual cells,
draining intracellular stores before they are restored by proinsulin production. Because we
currently assume a constant β-cell population, compensatory insulin release depends entirely
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Figure 5.4. β-cell function model behavior over three days for varying levels of food intake.
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lengthen the return time toward basal values. However, over the course of three days, there are
no significant changes in basal levels.
Nevertheless, UPR activity is altered due to increased nutrient excess. Glucose stimulates
the appearance of proinsulin in the ER, but this effect saturates for high glucose, leading to
a smaller increase in the protein. In addition, ∆AUC enhances UPR activation, which has
multiple effects. With 6-hour inter-meal periods, a sufficiently active UPR reduces the maximal
proinsulin levels reached after the first meal of the day, leading to a similar effect on XBP1
mRNA. When ∆AUC6 2, PERK inhibition due to residual chaperone elevation outweighs the ef-
fect of proinsulin-mediated activation, resulting in higher peak proinsulin with the second and
third meals of each day. Similarly, limited IRE1α responses reduce maximal XBP1 mRNA in-
duction. On the other hand, when ∆AUC> 2, increased PERK activity after breakfast decreases
the maximal proinsulin amounts attained with lunch and dinner. Simultaneously, increased
IRE1α activity leads to more drastic decreases in XBP1 mRNA than with smaller ∆AUC.
5.1.2 Summary
Our model of β-cell function reveals the nature of insulin production from the perspective
of an individual cell. Cellular function is preserved by the induction of the UPR in the presence
of elevated ER protein loads. This response reduces the stress placed on the cell while enhanc-
ing its capacity to process insulin for secretion into the blood. Once the cell has adapted to the
increased workload, it relaxes to a near-basal state. Glucose regulation therefore relies on the
ability of β cells to maintain a balance between supply and demand. Omitted from the present
framework is the consideration of β-cell mass plasticity, which can also impact the response to
a heightened demand for insulin.
5.2 Model of metabolic regulation with β-cell dynamics
5.2.1 Unregulated β-cell mass
β cells adapt to changes in the metabolic environment by altering their secretory capacity,
size, or number. Because the metabolic activities of these cells occur on a shorter time scale
than their population dynamics, significant modifications to β-cell numbers will only appear











to describe the dynamics of β-cell mass, B(t ). We ignore hypertrophic and hypotrophic effects
by assuming that all β cells have equal, constant volume, and we restrict ourselves to changes
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in total cell number. Henceforth, reference to β-cell mass is equivalent to that of β-cell number.
Glucose stimulates the replication of β cells according to a second-degree Hill function, which
is similar to the form used in De Gaetano et al. [24]. We further assume that de novo production
of β cells is negligible and that cellular turnover occurs at constant rate kb .
We explore the long-term interaction of nutrient excess, oxidative stress, mitochondrial
damage, and β-cell mass (Figure 5.5), by appending Equation (5.2) to a complete model com-
posed of systems (4.15) and (5.1). We eliminate equation (5.1e), and we replace (4.15b) with
(5.1f). We initialize the system under the assumption that glucose is in equilibrium according
to a given σ and set sˆ = (σ+hg −kg G0)/(G0U0) for each ∆AUC-determined σ. G(0)= 5 mM for
all ∆AUC.
Elevated nutrient intake initially leads to sharp increases in plasma glucose and insulin.
Similar behavior occurs in proinsulin and ER chaperones, accompanied by equivalent reduc-
tions in β-cell insulin protein and in the amount of GLUT4 at the membrane of skeletal muscle
cells. These rapid increases near time t = 0 occur because the system is not yet calibrated to
higher glucose loads, and they invoke an adaptive β-cell response in the form of increased
mass. Large ∆AUC promotes more profound β-cell mass expansion, which consequently re-
stores basal quantities of glucose and other glucose-responsive variables, including GLUT4,
unfolded proinsulin, and folded insulin.
Excess glucose also leads to increased skeletal muscle oxidative stress-mediated IRS-1 ser-
ine phosphorylation, which approaches an equilibrium level upon total mitochondrial damage.
When compared to the results of the model without β-cell dynamics, the timing of global
mitochondrial dysfunction remains the same. This is because the level of total glucose uptake
is identical to that of the previous model and similarly maintained at a constant rate. The
effects of muscle mitochondrial dysfunction, however, are different with the inclusion of β-cell
function. A jump in serine phosphorylation gives rise to an immediate decline in membrane
GLUT4, which creates a sharp increase in plasma glucose. The response of glucose under
these conditions influences β cells in two ways. On the one hand, intracellular proinsulin and
chaperone production rise, and more insulin protein is secreted. On the other hand, β-cell
mass responds to a greater demand for insulin with increased replication, leading to a higher
plasma insulin concentration. The spike in plasma insulin immediately reverses the effects
of dysfunctional skeletal muscle cells, as glucose, GLUT4, proinsulin, chaperones, and folded
insulin all return to their basal levels.












































































































































































































































































































































































eventually occurs (Figure 5.6). Initially, the elevated glucose input leads to a jump in the plasma
concentration; in contrast to the model with a dynamic β-cell population, this sharp rise is
never reversed. Glucose slowly increases, as insulin resistance develops. Additionally, insulin is
augmented with higher ∆AUC, but the magnitude of compensation is reduced, when compared
to the dynamics illustrated in Figure 5.5. Upon total mitochondrial dysfunction in muscle, the
secretory capacity of β cells is overwhelmed, and the glucose concentration reaches a steady
state within the impaired range (between 5.6 and 7 mM [3]). Amplified basal insulin secretion
is the result of increased glucose intake, which suggests that expansion of the β-cell population
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Figure 5.6. Dynamics of the full metabolic system with β-cell function and constant β-cell
mass. Units: plasma glucose, mM; plasma insulin, pM; β-cell mass, cells; glucose uptake,




The results of the full model reveal a progressively insulin-resistant state, characterized by
hyperinsulinemia and increased β-cell mass, along with a normal glucose concentration. With
higher ∆AUC, more insulin is required to combat the lower sensitivity of skeletal muscle cells
to insulin. As a result, individual β cells produce more proinsulin and secrete more insulin
into the blood. This process works for a time, but with skeletal muscle dysfunction, glucose
dysregulation occurs, forcing β cells to increase their mass in order to satisfy an increased
demand for insulin. This leads to a plateau of insulin at a higher level and the restoration
of the basal glucose concentration. The hallmark of this model is insulin resistance that is fully
compensated by β-cell secretory and replicative function.
Prior to the onset of complete mitochondrial dysfunction, UPR feedback minimally con-
tributes to the maintenance of normal glucose concentrations in the face of worsening insulin
resistance. A switch to predominately β-cell mass-mediated compensation occurs, relieving
the pressure on individual β cells. At this point, β cells secrete only a basal amount of insulin,
independently of ∆AUC, whereas insulin requirements are fully met with a greater number of
β cells. In this light, extreme nutrient excess can only ever lead to severe insulin resistance,
but not insulin deficiency, as in type 2 diabetes. These results suggest that negative feedback
on β-cell population dynamics or on β-cell function is necessary in the development of type 2
diabetes, which may also highlight a larger role for β-cell loss in disease development.
5.2.2 Apoptotic regulation of β cells
Heretofore, we have neglected the effects of UPR activation on the β-cell population. Pro-
longed activation of the UPR can generate regulatory proapoptotic signals, which occurs when
excessive ER stress impairs the cell’s ability to restore homeostasis [66]. In the case of constant
σ, β-cell loss can only occur within the average lifespan if glucose and insulin dynamics closely
track those of UPR-activated proapoptotic signaling (not shown). This suggests the presence of
more complex mechanisms driving the loss of β cells in diabetes development. We hypothesize
that the pattern of ingestion, along with the total amount of nutrient intake, makes a significant
difference.
The Trusina et al. UPR model demonstrates that the magnitude and duration of imposed
ER stress influences the benefit of translation attenuation [97]. As discussed in Section 5.1, in-
creased ∆AUC leads to delayed restoration of basal ER activity. It is the relatively short-term, yet
constitutive, activation of the UPR that can activate proapoptotic signals, thus altering β-cell
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turnover rates. Over the course of a lifetime, periodic meal pulses generate doses of ER stress
that, under normal circumstances, is reconciled prior to the significant activation of death
signals. With sufficiently large insulin demand, UPR activation, due to upregulated proinsulin
production and processing, is sustained over longer intervals; if stress attacks increase the ER
workload substantially, the protective response is further heightened, placing the cell in a more
precarious state than does an isolated challenge to the system.
As “prolonged” activation requires both pulsatile input and a failure to recover the basal
state, we explore the implications of periodic meals on PERK activity and β-cell dynamics. Let
Z (t ) be the level of proapoptotic activity, governed by
dZ
dt
= hz KPERK(uˆ(t )− uˆ0)−dz Z . (5.3)
Z increases according to the change in PERK from its basal level and is assumed to decay
rapidly with rate dz . The effect of proapoptotic signaling activity is to enhance β-cell turnover.











where ηz is the effectiveness with which Z mediates β-cell apoptosis.
We simplify the dynamics of the full system by restricting ourselves to a truncated timeline
of glucose metabolism, in which seven-day snapshots of metabolic regulation are taken for
discrete levels of insulin resistance (Figure 5.7). Food intake parameter σ is again applied as
a square wave for varying ∆AUC. Assuming an input of cytosolic hydrogen peroxide alters
the level of insulin resistance in a skeletal muscle cell over time, we include only the insulin
























where hydrogen peroxide, Rh , is treated as a parameter to specify the level of insulin resistance.
The four panels of Figure 5.7 correspond to ∆AUC = 0.5, with Rh = 0.0100, 0.0115, 0.0130,
and 0.0145, from left to right, where Rh = 0.01 is the basal hydrogen peroxide concentration
used in previous chapters. We assume that larger Rh values represent age-related worsening of





















































































































































































gray lines reflect glucose dynamics within a given life stage, and green lines their corresponding
proapoptotic activity. Progressive lightening of these lines indicates more advanced life stages.
During the adolescent period, glucose input is tightly regulated with each stimulus, as plasma
glucose returns to its basal level of 5mM. Similarly, the proapoptotic signal induced by UPR
activation returns to its initial level of zero. Through young adulthood and middle age, higher
levels of insulin resistance lead to increased UPR activation, β-cell apoptosis and elevated basal
glucose levels. At the height of insulin resistance in old age, glucose regulation is less ef-
ficient, and β-cell compensation is restricted by apoptosis to a larger extent than in earlier
stages. As a result, the effects of heightened insulin demands and β-cell decompensation are
more apparent. Overnutrition is less important because basal glucose levels fall well within the
normal range, that is, below 5.6 mM, even with an age-related increase in insulin resistance.
Nevertheless, this example suggests that over an extended period of time, the combined effect
of increased β-cell function and apoptotic feedback mechanisms, along with nutrient overload
and a sufficiently high insulin demand, promotes gradual β-cell loss.
5.3 Discussion
Our model gives insight into the nature of β-cell function, from both a natural and compen-
satory standpoint. Adaptation of β cells to changes in insulin demand occur at both molecular
and population levels. When the increase in the requisite concentration of insulin to maintain
normoglycemia is small, β cells can adapt by increasing insulin secretion per cell. However,
in the case of severe insulin resistance, more dramatic changes in β-cell mass are necessary
to conserve individual cellular function and meet metabolic demands. This compensatory be-
havior protects β cells from ER stress, thereby limiting UPR induction. Our model implies that
such a mechanism is enough to prevent the development of type 2 diabetes. However, with the
consideration of proapoptotic consequences of constitutive UPR activation, we find that β-cell
mass is more susceptible to loss with increasingly severe insulin resistance, supporting the
additive effect of increased apoptosis as an additional mechanism for β-cell decompensation.
Although improperly folded proinsulin leads to its UPR-mediated degradation, an explicit
description of these proteins has been omitted from our model [79]. The role of misfolded
proteins in β-cell function resembles that of unfolded proteins, as they also induce UPR ac-
tivity. We indirectly include abnormal proinsulin processing by assuming that some fraction
of the proinsulin degraded also includes degraded misfolded proinsulin. With this in mind,
consideration of these abnormal proteins in the UPR framework would not contribute signifi-
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cant changes to the model. Still, as the demand for insulin increases, the likelihood that folding
mistakes are made also increases, and misfolded proteins will aggregate more quickly when the
ER is overworked [66]. The additional biological complexity this creates is important if the UPR
is more sensitive to abnormally folded proteins than unfolded ones, in either its initiation or
targeting effector responses. We hypothesize that explicitly described misfolded proteins can
reduce the amount of folded insulin protein through competition, wherein more chaperone
activity would be diverted from proinsulin folding to degradation of defective proteins. It re-
mains to be determined whether such a reduction in folded protein would significantly impact
the plasma insulin concentration.
Notably, the snapshots presented in Figure 5.7 are not illustrative of the typical trajectory for
glucose metabolism during the course of a lifetime. Instead, they represent isolated responses
to a particular level of insulin resistance. This is important because we assume identical initial
conditions for each 7-day period, ignoring the metabolic changes that may have occurred prior
to the beginning of each phase. Were this model solved for thrice-daily meals over several
decades, we hypothesize that the glucose excursions seen in the “old age” phase would deviate
farther from the basal level, as the cumulative metabolic history would determine the initial
state of this life stage.
In this chapter, we have completed a model of glucose metabolism and mechanisms of dys-
function. It is evident that a multitude of causative factors are responsible for the progression
of type 2 diabetes, and we have highlighted oxidative stress, mitochondrial dysfunction, and
the unfolded protein response as sources of metabolic dysregulation in disease development.
CHAPTER 6
CONCLUSION
This work has focused on the coordinated function and dysfunction of skeletal muscle and
β cells in glucose metabolism. We have provided a mathematical model of the mechanisms
underlying age- and glucose-mediated skeletal muscle insulin resistance, and we have detailed
its impact on the dynamics of the glucose-insulin regulatory system, with particular attention
to mitochondrial abnormalities and oxidative stress. We have also presented a model of β-cell
function, with feedback provided by the unfolded protein response, to outline mechanisms of
β-cell decompensation. Combining these models, we have developed a long-term mathemati-
cal model of mechanisms underlying the progression of type 2 diabetes.
Skeletal muscle is the major tissue addressed in our discussion of insulin resistance. How-
ever, other insulin-responsive tissues do acquire insulin resistance, particularly in obesity. In
this chapter, we discuss mechanisms of obesity-related dysfunction in type 2 diabetes patho-
genesis for consideration in future work.
Obesity is highly correlated with type 2 diabetes, yet less than half of obese individuals
actually develop the disease. This fact may be explained by a propensity toward β-cell dys-
function in this subset [28], but less straightforward is the reason for inter-individual variability
in the molecular presentation of obesity-related insulin resistance, which can also impact the
likelihood of disease manifestation. As such, we look to mechanisms of adipose tissue insulin
resistance and its systemic effects for answers.
Conditions of overnutrition often result in the expansion of white adipose tissue, which
comprises subcutaneous and visceral subtypes, SAT and VAT, respectively. SAT and VAT are the
major sites for fat storage, and because they are functionally distinct, fat partitioning may play
a role in the development of obesity-related diabetes [69]. Predominant fat storage in SAT may
systemically provide protection from fat-mediated defects, whereas VAT storage of fuel excess
leads to progressive tissue dysfunction and insulin resistance [69,89]. This generates questions
regarding the specification of adipocyte phenotypes and the switch underlying preferential
expansion in an over-fueled environment.
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Associated with increased adiposity is inflammation, which is one source of systemic in-
sulin resistance. Recruitment and infiltration of macrophages in expanding adipose tissue,
particularly in VAT [102], is now the widely accepted origin of the elevated TNFα expression ob-
served in obesity [6, 82]. Interestingly, the distribution of resident adipose tissue macrophages
is thought to be divided between the classically activated, Th1-mediated M1 phenotype and the
alternatively activated, Th2-mediated M2 phenotype [61]. It is proposed that dynamic remod-
eling or switching of adipose tissue macrophage phenotypes occurs in a state of obesity, but
the precise mechanism remains to be elucidated [28, 61]. Notably, dysfunctional VAT appears
to produce more proinflammatory cytokines than SAT does [28, 89], and pathological function
of antibody-producing B cells may contribute to such production [102]. We can address the
question of phenotypic expression of macrophages either alone or in the context of distinct
expanding adipose tissue environments.
Inflammation and adipose-secreted cytokines can cause insulin signaling defects through
inhibitory serine phosphorylation of the IRS proteins in various tissues [2, 20]. We now discuss
insulin action and insulin resistance in adipose tissue, to further dilineate the systemic effects
of obesity-induced inflammation. Insulin signals triglyceride (TG) synthesis in adipocytes for
storage and greatly inhibits lypolysis and the release of free fatty acids (FFAs) into plasma [105].
Insulin resistance in these tissues therefore reduces TG synthesis and increases FFAs in the
blood, for which other tissues and organs can compensate by storing fat. Preferential lipid
synthesis in skeletal muscle and liver, however, reduces glucose oxidation and uptake, thus
desensitizing these cells to insulin [80]. Furthermore, the TG precursor, diacylglycerol (DAG), is
more recently believed to directly initiate signaling events that promote serine phosphorylation
of IRS proteins and insulin resistance [6]. Endocrine function is also at risk, as increased con-
centrations of circulating FFAs are toxic to β cells, providing an additional basis for β-cell failure
in type 2 diabetes [56, 80]. We can therefore assess the role of FFAs as additional mediators of
systemic insulin resistance and glucose dysregulation in late type 2 diabetes development.
Liver dysfunction in type 2 diabetes is also exacerbated by the presence of adipose tissue
insulin resistance. The increased release of FFAs from these tissues can result in enhanced
lipogenic activity and fat accumulation in the liver, resulting in hepatic insulin resistance [82].
Such resistance reduces insulin’s ability to suppress hepatic glucose production after eating,
which can to lead to fasting hyperglycemia [69,90]. However, metabolic dysfunction of the liver
seems to rely on preexisting abnormalities that carry more weight than increases in glucose
production, which themselves resemble elevated dietary sugar intake [69]. Hence, we deem
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adiposity as the reasonable next step on which we can expand our mechanistic treatment of








































































































































































































































































Table A.1 is a comprehensive annotated list of all parameter values. Each value is discussed
in detail in the following sections.
Table A.1. List of all parameter values used in the main text. *See text for details.














aa 1.04×10−2 min−1 ∗
ae 104.1667 min
−1 ∗
B 1000 106 cells [24]
Gh 9.0 mM [24]
hg 0.025 mM min
−1 derived
hi 2.8744×10−2 (106 cells)−1 min−1 derived
kc 1200 min
−1 ∗
ke 7.6678×10−4 min−1 ∗
kg 0 min
−1 [24]
kg i 1.282×10−3 derived
ki 0.05 min
−1 [24]





qr 8×10−5 # ∗
S 10−4 pM−1 min−1 [24]
v1 1/19.5 # ∗
v2 15600 # ∗
























K 500 mitochondria ∗
µ 10−6 # ∗
s 0.08 # [60]
Continued on next page
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Table A.1. Continued



























Ih 1.2×103 pM ∗
jˆ 200.0 µM [104]
Jmax 2.0 # ∗
pˆ 1.64909 # ∗


















ηz 0.5 # ∗
Ghb 5 mM [24]
hb 0.0334 d
−1 derived
hˆi 1.158×10−9 pM molecule−1 (106 cells)−1 derived
huc 500 molecules (mRNA level)
−1 min−1 [97]
huu 2.5×107 molecules min−1 [84]






KPERK 100 # [97]
ku f 0.002 mM





K2 6000 molecules [97]
K3 2×105 molecules [97]
qu f 0.9 mM
−1 min−1 ∗





• Initial conditions. We make the assumption that F ′1(0) = 0 for all variables F1(t ) in sub-
system (2.1). As in [24], we assume that plasma glucose and insulin take on their basal
values initially: G0 = 5 mM and I0 = 50 pM, respectively. Because intracellular glucose
concentrations are difficult to determine [106], we arbitrarily set Gi 0 = 1 mM.
• β-cell mass, B. β-cell mass is estimated to be on the order of 109 cells in [24]. In millions
of cells, we therefore use B = 1000.
• Half-maximal glucose stimulation, Gh . As in [24], we use a value of 9.
• Hepatic glucose production, hg . With the assumption that G ′(0) = 0 without additional
glucose input due to diet, we derive hg to be kg G0+SG0I0 = 0.025.
• Insulin production, hi . With I ′(0)= 0, hi is derived to be ki I0(G40+94)/(BG40)= 0.028744.
• Insulin-independent glucose uptake, kg . This version of the glucose subsystem is adapted
from a previous model by [24]. The value used is therefore kg = 0.
• Glycolytic rate, kg i . From G ′(0)= 0, this value is derived to be
kg i = v1SG0I0/Gi 0 = 0.001282.
• Insulin clearance, ki . First-order clearance of insulin is assumed to occur at a normal rate
of 5% per minute, as in [24].
• Insulin sensitivity, S. In the case of constant insulin sensitivity, we use a value of 0.0001,
as in [24].
• Food intake parameters, σ and ∆AUC. We obtain the physiological range of ∆AUC ∈ [0,4]
from continuous glucose monitoring studies [17]. The derivation of σ is described in
Chapter 2. The average glucose input rate is σ = hg∆AUC/G0 per minute. σ is thus
estimated to range from 0 to 1/72000.
• Glucose distribution, v1. Skeletal muscle fiber diameters range between 10 and 100 mi-
crons, with variable diameters on the order of centimeters [58]. We first estimate the
volume of a single skeletal muscle fiber by using a radius of 0.005 cm and an average
height of 5 cm. Using the cylindrical volume, we estimate the cytosolic volume of a single
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fiber to be 3.9× 10−7 L. With a plasma volume of ∼ 4 L [36] and an arbitrary skeletal
muscle cell number of 2.0×108,
v1 = 4




describes the conversion factor of plasma glucose into a single cell.
A.1.2 Mitochondrial subsystem
• Initial conditions. We make the assumption that F ′2(0) = 0 for all variables F2(t ) in sub-
system (2.4). The steady-state superoxide concentration within the mitochondrial matrix
has been estimated to exist in picomolar concentrations [67, 83]. We therefore use the
estimated value of Rs0 = 10−5 µM. In [83], the initial MnSOD concentration is taken to be
the steady-state value of As0 = 5. All mitochondria are assumed to be perfectly efficient
initially, implying L0 = 0. We derive the initial reduced complex concentration to be
C0 =
v2Ne Kg i Gi 0Ctot
v2Ne Kg i Gi 0+kc
. E0 is derived to be qakr sRs0 As0/aa .
• MnSOD production, aa . It is assumed that the maximal level of MnSOD production
meets the steady-state antioxidant concentration after 8 hours. We therefore compute
aa = As0
60 ·8 = 0.0104 µM min
−1.
• MnSOD signal activation, ae . The steady-state concentration of superoxide, Rs0, is as-
sumed to maximally stimulate MnSOD production activity within 16 hours. The rate of
signal activation then becomes ae = 1
60 ·Rs0 ·16
= 104.1667.
• Rate of cellular respiration, kc . kc is derived from the initial equilibrium assumption:
v2Ne kg i Gi 0(Ctot −C0)
C0
= 1200.
• MnSOD signal deactivation, ke . ke is derived to be ae Rs0(1−E0)/E0 = 7.6678×10−4.
• Superoxide dismutation, kr s . MnSOD is known to interact with superoxide at a rate ∼
O (109) M−1 s−1 [34, 35, 83]. As in [35], we use kr s = 2.4×105 µM−1 min−1.
• Total electron contribution, Ne . Each unit of glucose contributes 20 electrons to the elec-
tron transport chain. Thus, we assume Ne = 20 per mM [59].
• MnSOD damage probability, qa . We assume 0.1% of all reactions between MnSOD and
superoxide result in irreversible MnSOD damage.
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• Fractional superoxide production, qr . The fraction of oxidative phosphorylation in iso-
lated mitochondria resulting in superoxide production has been found to lie between
0.001 and 0.04 [31, 49, 98]. It is estimated that in vivo this percentage is much smaller
[32, 67]. We therefore choose qr = 8×10−5.
• ETC conversion factor, v2. It is estimated that up to 20% of skeletal muscle cell volume
comprises mitochondria [58]. With a skeletal muscle cytosolic volume of 3.9× 10−7 L
and a mitochondrial population of 500, an individual mitochondrial matrix volume of
0.05 µm3 or 5× 10−11 L yields a total volume that is between 5 and 10% – once the
volume of the intermembrane space is taken into account – of the cell volume. Using
this information, v2 is calculated to be
103 · (3.9×10−7)
K · (5×10−11) = 15600.
• Mitochondrial dysfunction, ξ. Mutagenic lesions created by superoxide-mediated gua-
nine oxidation of mtDNA can lead to alterations in the mitochondrial genome [30, 64],
but an accumulation of deleterious mutations above a threshold is required before de-
fective oxidative phosphorylation is manifest [21]. Furthermore, the fraction of genes
implicated in cellular respiration is 35%, further reducing the overall effect on mitochon-
drial efficiency [99]. We therefore assume a low rate of appearance of mitochondrial
inefficiency due to superoxide: ξ= 8×10−6.
A.2 Mitochondrial selection
• Mitochondrial growth rates, b0 and b1. We assume growth of the undamaged mitochon-
drial class balances its turnover. Hence b0 = 0.07. Because damaged mitochondria expe-
rience a growth disadvantage, we use s to derive the growth rate for this subpopulation:
b1 = (1− s)b0 = 0.0644.
• Fractional scavenging resistance, c. As in our sensitivity studies, we find that an exces-
sive survival advantage, e.g., 0.4, for damaged mitochondria eliminates the effects of
their growth disadvantage. At the same time, extremely small differences in scavenging
susceptibility reverse the stability condition (3.6). In consideration of these effects, we
choose to represent the damaged mitochondrial survival advantage by c = 0.2.
• Mitochondrial turnover rates, d0 and d1. Mitochondrial DNA is estimated to turnover
approximately once every two weeks [30]. Thus, we set d0 = 0.07. Taking into account
the fractional resistance to mitophagy, we set d1 = (1− c)d0 = 0.056.
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• Mitochondrial population size, K . Mammalian cells have, on average, between 103 and
104 copies of mtDNA, with each mitochondrion housing 2–10 copies [88]. Assuming a
skeletal muscle cell copy number of 5000 with a per-mitochondrion number of 10 (as
in [74]), we set K = 500.
• Damage transition probability, µ. The transition from healthy to damaged mitochondria
is assumed to be small due to the slow accumulation of internal dysfunction that would
lead to a fully oxidatively stressed mitochondrion. Thus, we use µ= 10−6.
• Fractional growth deficit, s. It is estimated that the growth difference between healthy
and damaged is no more than 10% [60]. As such, we use s = 0.08.
A.3 Insulin signaling system
• Initial conditions. We make the assumption that F ′3(0) = 0 for all variables F3(t ) in the
simplified insulin signaling system (4.10). We assume that baseline serine phosphoryla-
tion has no inhibitory effects. This assumption is based on the idea that in the absence
of insulin stimulation, IRS-1 is phosphorylated on 12 of 40 serine sites [20]. Assuming
that basal insulin contributes no additional serine phosphorylation, we set Ps0 = 0.3. We
then derive the initial condition for tyrosine phosphorylation: Py0 = Ir 0(1−Ps0)
Ir 0(1−Ps0+δy /αy
.
In Sedaghat et al. [85], the fraction of GLUT4 at the cellular membrane, in the absence
of insulin stimulation, is taken to be 0.04. Created from this model is an insulin-GLUT4
curve that yields a half-maximal stimulatory insulin concentration of roughly 200 pM.
Under maximal insulin stimulation of 106 pM, GLUT4 expression at the cell surface is as-
sumed to be 0.4. We therefore assume that the initial fraction of GLUT4 at the membrane
is U0 = 0.04+ (0.4−0.04) I0
I0+200
. As recorded in [83], we set the initial concentration of
hydrogen peroxide to Rh0 = 0.01 µM.
• Catalase concentration, Ah . This value is assumed to be constant at the steady-state
concentration, estimated to be roughly 3 [83].
• Serine phosphorylation, αs . This parameter is derived to be αs = δsPs0( jˆ +Rh0)
JmaxRs0(1−Ps0)
.
• Basal GLUT4 translocation, αu . This value, also taken from [85], is set to be αu = 0.00696.
• Tyrosine phosphorylation, αy . The model of inuslin signaling by Sedaghat et al. models
the general phosphorylation of IRS-1 [85]. As this activity results in downstream activa-
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tion of elements in the insulin signaling cascade, we assume the rate of phosphorylation
used corresponds to that of tyrosine activation on IRS-1. Hence, we set αy = 4.16.
• Hydrogen peroxide removal, δr h . As reported in [83], we take this value to be 3000.
• Serine dephosphorylation, δs . This value is arbitrarily set to 0.0001 to ensure the dynam-
ics of serine phosphorylation occur on the same time scale as those of tyrosine phospho-
rylation.
• GLUT4 internalization, δu . From [85], we use δu = 0.167.
• Tyrosine dephosphorylation, δy Taken from [85], δy = 0.33557.
• Half-maximal insulin activity, Ih . Activity of the insulin receptor is assumed to be equiv-
alent to the bound fraction of receptors. In [85], the percent of maximal activity of insulin
receptors for a 50 pM (I0) concentration of insulin is roughly 4%. Since we define total
receptor activity to be Ir = I
I + Ih




• PKB-mediated GLUT4 translocation, ηp . As in [85], we use ηp = 0.104375.
• Half-maximal JNK activation via hydrogen peroxide, jˆ . Given experimental evidence of
JNK activation and maximal effects, a half-maximal concentration of 200 µM hydrogen
peroxide is assumed from [104].
• Maximal JNK activity, Jmax. It has been reported that millimolar concentrations of hydro-
gen peroxide may induce JNK activation more than five-fold. However, the actual activity
level of the stress protein is unclear. In the work of Yoshizumi et al., JNK phosphoryla-
tion does not appear to saturate with 1 mM hydrogen peroxide. Given that steady-state
hydrogen peroxide exists in nanomolar concentrations, it is assumed that maximal JNK
activation in vivo saturates at an arbitrary level of 2.
• Half-maximal PKB activity, pˆ. As derived in Chapter 2, pˆ = δp /αp . In [85], δp = 10ln2.





Hence, we use pˆ ≈ 1.64909.
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• Fractional hydrogen peroxide appearance, qh . With the hydrogen peroxide concentration
at equilibrium initially, we derive qh to be δr h AhRh0/αhRs0K . Note that αh = 2kr s As0.
As defined previously, the steady-state concentration of MnSOD (As0) is estimated to be
about 5 µM [83] and the superoxide dismutation rate 2.4 ·105 [35]. We therefore use qh =
0.015.
• Rate of glucose uptake, sˆ. This parameter is derived to be (σ+hg −kg G0)/G0U0 and varies
according to the value of σ.
A.4 β-cell function
• Initial conditions. We make the assumption that F ′4(0) = 0 for all variables F4(t ) in the
β-cell function system, comprising Equations (5.1), (5.3), and (5.4). As before, we use
G0 = 5, I0 = 50, and B0 = B = 1000. To reflect a substantial number of existing proinsulin
molecules, we set Buu0 = 106, based on the magnitude assumed in [97]. We assume
arbitrary units for Bux , as there is no qualitative change in the subsystem containing
the unfolded protein response when different magnitudes of the variable are considered.
Hence, we arbitrarily set Bux0 = 10. We assume there is no apoptotic signal present
initially, so that Z0 = 0. Based on the equilibrium assumption, we derive Buc0 = (σuc +




• ER chaperone decay, duc . This value is set to 1/120 [97].














• XBP1 mRNA decay, dux . This value is set to 1/30 [97].
• Proapoptotic signal decay, dz . Under the assumption that proapoptotic signal decay is
much faster than activation, we set dz = 2.0.
• Apoptotic effectiveness, ηz . We assume β-cell decay is doubled when Z = 2, and thus set
ηz = 0.5.
• Half-maximal glucose stimulation of β-cell replication, Ghb . As in [24], this value is set to
the steady-state glucose concentration of 5.0.
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• β-cell replication, hb . This parameter is derived to be kb(G20+G2hb)/G20 = 0.0334.
• Plasma insulin conversion factor, hˆi . This parameter is derived to be
hˆi = ki I0
ku f Bu f 0G0B0
≈ 1.158×10−9.
• XBP1-dependent chaperone production, huc . This value is set to huc = 500 [97].
• Proinsulin production, huu . Glucose stimulates proinsulin production in a sigmoidal
manner. Maximal stimulation by glucose can lead to a 25-fold increase in proinsulin syn-
thesis, compared to a minimally stimulated rate of 106 [84]. Thus, we set huu = 25×106.
• IRE1α-induced XBP1 mRNA activation, hux . This parameter is derived to be
hux = dux Bux0
uˆ0
≈ 6.2239.
• Proapoptotic signal activation, hz . We assume that PERK activation above the initial
steady-state level initiates a full apoptotic signal every two hours. Thus, we set hz =
1/120.
• β-cell turnover, kb . Adult β cells have a lifespan of about 60 days [78]. We therefore set
kb = 1/60.
• Maximal PERK activity, KPERK. This value is set to 100 [97].
• Insulin protein secretion, ku f . Maximal insulin release upon glucose stimulation occurs
at a rate of roughly one granule every three seconds [15]. With each β-cell containing
∼ 104 secretory granules [16], we derive a secretion rate of 0.2% min−1 per mM glucose.
Thus, we set ku f = 0.002.
• Proinsulin-chaperone Michaelis-Menten constant (folding/degradation), Kuu . This value
is set to 104 [97].
• PERK/IRE1α-proinsulin dissociation constant, K1. This value is set to 106 [97].
• PERK/IRE1α-chaperone dissociation constant, K2. This value is set to 6000 [97].
• Proinsulin-chaperone dissociation constant (chaperone sequestration), K3. This value is
set to 2×105 [97].
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• Proinsulin folding fraction, qu f . We assume that 10% of all proinsulin removal results
in direct degradation of proinsulin or indirect degradation via misfolded proinsulin. The
remainder is assumed to be properly folded. Thus, we set qu f = 0.9.
• Basal chaperone production, σuc . This value is set to 1.5 [97].
APPENDIX B
MODIFIED GILLESPIE ALGORITHM
The Gillespie algorithm, also known as the Stochastic Simulation Algorithm [37], gives a sta-
tistically exact realization of the chemical master equation, which describes the time-evolution
of the probability density function of multiple states in a system. The stochastic mitochondrial
selection model is a two-state system of damaged and undamaged mitochondria. To reduce the
computational time used in the simulation of this system, we implement a modified version of
the Gillespie algorithm, which accounts for the tendency of the system to return to 500 from
499 healthy mitochondria.










Step 0. Calculate the analytical expected extinction times from M0 = i mitochondria, denoted
Ti . Set λ¯= 1/(TK −TK−1). This is the average time it takes for one undamaged mitochon-
drion to be lost from an entirely healthy population.
Step 1. Initialize the system: j = 0, t0 = 0, M 00 =K , M 01 = 0.
Step 2. Calculate the transition probability rates vi , i = 1,2,3, where
v1 = d0M0µb0M0+b1M1
b0M0+b1M1









Step 3. Choose τ from an exponential distribution with rate λ = v0, and u from a discrete
uniform distribution with n = 3. τ determines the time at which the next event occurs,
and u determines the event au to occur.
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(a) If M j+10 6= 500, update j = j +1.
(b) If M j+10 = 500, choose τ¯ ∼ exp(λ¯). Reset M
j+1
0 = 499, M
j+1
1 = 1, and t j+1 = t j+1+ τ¯.
Update j = j +1.
Return to Step 1.
APPENDIX C
SOLUTION TO THE MODIFIED GAMBLER’S
RUIN PROBLEM
We derive the solution to the modified Gambler’s Ruin problem formulated in Chapter 3.




= [a1 a2 a3]= [+1 −1 0−1 +1 0
]
describes the three possible outcomes of an event in the stochastic model. Let pi = Pr(a1|M0 =
i ) and qi = Pr(a2|M0 = i ). Then 1−pi −qi = Pr(a3|M0 = i ). Let bi and di be the birth and death
rates of mitochondrial subpopulation i , i = 0,1. Let µ be the probability that an undamaged
mitochondrion transitions to a damaged one. M0+M1 =K implies that M1 =K −M0. Then
pi = d1(K − i )
d0i +d1(K − i )︸ ︷︷ ︸
death from C1
· (1−µ)b0i




d0i +d1(K − i )︸ ︷︷ ︸
death from C0
· µb0i +b1(K − i )
b0i +b1(K − i )︸ ︷︷ ︸
transition/birth to C1
, so that
1−pi −qi = d1(K − i )
d0i +d1(K − i )︸ ︷︷ ︸
death from C1
· µb0i +b1(K − i )
b0i +b1(K − i )︸ ︷︷ ︸
transition/birth to C1
+ d0i
d0i +d1(K − i )︸ ︷︷ ︸
death from C0
· (1−µ)b0i
b0i +b1(K − i )︸ ︷︷ ︸
birth to C0
.
Let Wi be the probability that M0 will equal K before it reaches zero, having begun with
M0 = i . In general,
Wi = pi Wi+1+qi Wi−1,
and WK = µWK−1. Now, let Li be the probability that M0 = 0 will occur before M0 = K from i
mitochondria. Then
(1−Li )= pi (1−Li+1)+qi (1−Li −1)
⇒ Li = (1−pi −qi )+pi Li+1+qi Li−1.
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Let Ti be the expected time until M0 = 0 from M0 = i , and let Ei be the average duration of time
between events. Then
Ti = (1−pi −qi )(Ti +Ei )+pi (Ti+1+Ei )+qi (Ti−1+Ei )
⇒ qi Ti−1− (pi +qi )Ti +pi Ti+1 =−Ei ,
with boundary condition T0 = 0. Let ∆i = Ti+1−Ti . Then
pi (Ti+1−Ti )−qi (Ti −Ti−1)=−Ei
⇔ pi∆i −qi∆i−1 =−Ei





and letting ρi = pi
qi
and ηi = Ei
qi
gives ∆i−1 = ρi∆i +ηi . We proceed by solving this equation












































































, i = 1, . . . ,K −1,
TK =ηK +TK−1.
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